1. Introduction {#sec0001}
===============

The COVID-19 is a communicable disease which is caused by coronavirus of a new kind. As of 21st January 2020, only 4 countries namely: China (278 cases), Republic of Korea (1 case), Thailand (2 cases) and Japan (1 case) were affected with a total of 282 confirmed cases including 6 deaths [@bib0001]. The United States recorded its first case on 23rd January 2020 as a result of an exported case from China [@bib0002]. This amounted to a total of 581 confirmed cases. France and Australia also reported 3 confirmed cases each while China's confirmed cases were exponentially increasing summing the total confirmed cases to 1320 as of 25th January [@bib0003]. Germany joined the race on 28th January with reported case of 1 [@bib0004]. Italy also reported its first 2 confirmed cases on 31st January 2020 contributing to 9826 globally confirmed cases [@bib0005]. The first-time a Health Care Worker was diagnosed with coronavirus happened in France on 1st February 2020. Spain and the United Kingdom reported their first confirmed cases on the same day each with 1 and 2 cases respectively [@bib0006]. Philippines recorded the first death outside China on 1st February 2020 [@bib0007]. The first African country to report a confirmed case was Egypt on 14th February 2020 [@bib0008]. The statistics as of 19th June, 2020, 06:25 GMT showed that, there were 8,586,115 confirmed cases, 456,458 confirmed deaths and 4,535,245, recovered cases globally [@bib0009]. Ghana recorded its first confirmed cases on 12th March, 2020 [@bib0010]. These were 2 imported cases from Norway and Turkey. Prior to the identification of these cases, effective measures such as testing and public education had been put in place to create awareness which demonstrated the country's preparedness to face this pandemic [@bib0011]. Earlier measures after the first incidence included; a ban on individuals from countries which had recorded over 200 cases and 14 days mandatory quarantine for all persons who were allowed to enter its territory. Also, as part of the early measures against the spread, schools, conferences, social gatherings, sporting activities and political rallies were all halted as enhanced measures against the spread of COVID-19 [@bib0012]. On 30th March 2020, Accra and Kumasi which are the major cities in the country experienced lockdown together with some internal travel restrictions. Ghana had recorded 12,929, confirmed cases including 66 deaths and 4,468 recovered with 8,395 active individuals as of 18th June, 2020 [@bib0011]. It is important to note that these deaths were also attributed to risk factors such as hypertension, diabetes and other cardiovascular diseases [@bib0011]. In [Fig. 1](#fig0001){ref-type="fig"} a and [1](#fig0001){ref-type="fig"}b we show the daily reported cases per day as of 18th June 2020. Since the outbreak of COVID-19, many mathematical models have provided some insightful ideas to health authorities on how best to control the disease spread. For example, see the works of [@bib0013], [@bib0014], [@bib0015], [@bib0016], [@bib0017], [@bib0018], [@bib0019], [@bib0020], [@bib0021]. Asamoah et al. [@bib0022] studied an (*SEAQI~s~HRRADS~p~*) model to describe COVID-19 human-human transmission dynamics for Ghana and Egypt; and obtained various epidemiological parameter values. They suggested that: a continuous increase in the rate of diagnoses, the rate of quarantine through doubling enhanced contact tracing, and stringent safety measures in hospitals (and/or isolation centres); with a constant supply of effective personal protective equipment's (PPEs) will help reduce the control reproduction number $\mathcal{R}_{c},$ to less than unity as the lockdown measures are been lifted. Adding natural recovery to their model, they showed that an increase in natural recovery from the asymptomatic stage reduces the control reproduction number. They also noticed that the choice of a force of infection influences the control reproduction number. Although, human to human mathematical analysis has been established, not much mathematical analysis is done on the dynamics of the virus in the environment and the role human play by releasing the viruses into the environment. The mathematical model that studied the role of the environment focused on the seafood market in Wuhan and used Atangana-Bleanu-Caputo operators for their investigation without the use of optimal control model [@bib0023] (see also [@bib0024]). The work by Zhang et al. [@bib0025] discussed the airborne transmission as the main route for the spread of COVID-19. Ferretti et al. [@bib0026], also quantified SARS-CoV-2 transmission dynamics and noticed that, 6% of the secondary outcomes can be linked to environmental transmission. They also noted that, presymptomatic transmissions can sufficiently maintain the epidemic growth. Hence, we want to study the mathematical dynamics of viral load in the environment and the use of non-pharmaceutical measures together with cost-effectiveness analysis. Thus, by developing a mathematical and optimal control model for human-environment-human transmission dynamics. Despite that other optimal control model on COVID-19 have been studied (see for example [@bib0027], [@bib0028], [@bib0029], [@bib0030], [@bib0031], [@bib0032]). But, to the best of our knowledge, there exists no compartmental model which focuses on environment to human dynamics of COVID-19 in Ghana together with cost-effectiveness analysis. Hence, this paper will contribute to the existing knowledge on the spread of COVID-19 and the dynamical influence of the virus in the environment through human activities in Ghana. It will also assist health care authorities and the government to see the optimal trajectory of the implementation of non-pharmaceutical interventions.Fig. 1Daily Infected trend and bar plot for confirmed cases for Ghana.Fig. 1

The rest of this paper is partition as follows: [Section 2](#sec0002){ref-type="sec"} contains the model formulation, definition of model parameters, invariant region, boundedness, equilibrium points and stability analysis. [Section 3](#sec0009){ref-type="sec"} contains the model fit, parameter estimation, and sensitivity analysis. [Section 4](#sec0012){ref-type="sec"} contains optimal control problem and cost-effectiveness analysis. In [Section 5](#sec0015){ref-type="sec"}, we give concluding remarks and recommendations.

2. Model formulation and analysis {#sec0002}
=================================

This section discusses the transmission dynamics of COVID-19, model analysis, properties and the equilibrium points, computation for the basic reproductive number and the stability analysis. In dealing with the dynamics of COVID-19 so as to implement the necessary control measures, we consider the compartments; Susceptible (S), Exposed/pre asymptomatic (E), Asymptomatic (A), Symptomatic (I), Recovery (R) and the Virus in the Environment, thus, on surfaces (V). As a deterministic model, we suppose that, the compartments depend on time. The total population of individuals, *N*(*t*) at time *t* is given as; $N\left( t \right) = S\left( t \right) + E\left( t \right) + A\left( t \right) + I\left( t \right) + R\left( t \right)$. We also consider that all parameters are positive and it is only the *I* compartment which experiences disease induced death at a rate, *α*. The overall force of infection is given as $\lambda = S\left\lbrack \beta\left( \eta A + I \right) + \beta_{1}V \right\rbrack$. The model further assumes that, no exposed individual transmits the disease. The proportion of those in *E* class into both *A* and *I* classes is given as $k_{2}\left( 1 - \gamma \right)E$ and *k* ~1~ *γE* respectively. Similarly, individuals recovering from the *A* class is $v_{2}\left( 1 - \phi \right)A$ and those joining the *I* class from the *A* compartment is *v* ~1~ *ϕA*. Though, not much had been said with regards to the possibility of the recovered individuals joining the susceptible population. All the same we included it so to ascertain the impact of short and long-term immunity on the dynamics of COVID-19, denoted as *ρ*, where *ρ* ≥ 0. [Table 1](#tbl0001){ref-type="table"} further explains the individual parameters.Table 1Parameters with their interpretation for model [(1)](#eq0001){ref-type="disp-formula"}.Table 1ParameterDescriptionΛRecruitment rate*λ*Force of infection*ω*Natural death rate*β*Transmission rate*β*~1~Transmission rate from the environment*η*Relative transmissibility of asymptomatic individuals*γ*Proportion of individuals who are timely diagnosis*k*~1~Progression rate from exposed to the symptomatic (severely infected) class*k*~2~Progression rate from exposed to the asymptomatic class*α*Disease induced death rate*ϕ*Proportion of asymptomatic patients who later move to the symptomatic (severely infected) class*v*~1~Progression from asymptomatic to the symptomatic (severely infected) class*v*~2~Progression from asymptomatic to the recovered classϵThe rate at which symptomatic (severely infected) patients recovers*ρ*The rate at which the recovered individuals join the susceptible class*τ*~1~Natural decay rate of virus from the environment (Surfaces)*m*~1~The rate of viral release into the environment by asymptomatic patients*m*~2~The rate at which symptomatic patients release virus into the environment

The differential equations of the COVID-19 model in [Fig. 2](#fig0002){ref-type="fig"} are given below as;$$\begin{aligned}
\frac{dS}{dt} & {= \Lambda - \omega S - \beta\left( IS + \eta AS \right) - \beta_{1}VS + \rho R,} \\
\frac{dE}{dt} & {= \beta\left( IS + \eta AS \right) + \beta_{1}VS - k_{2}\left( 1 - \gamma \right)E - k_{1}\gamma E - \omega E,} \\
\frac{dA}{dt} & {= k_{2}\left( 1 - \gamma \right)E - \omega A - v_{1}\phi A - v_{2}\left( 1 - \phi \right)A,} \\
\frac{dI}{dt} & {= k_{1}\gamma E + v_{1}\phi A - \epsilon I - \left( \omega + \alpha \right)I,} \\
\frac{dR}{dt} & {= v_{2}\left( 1 - \phi \right)A + \epsilon I - \rho R - \omega R,} \\
\frac{dV}{dt} & {= m_{1}A + m_{2}I - \tau_{1}V,} \\
\end{aligned}$$given that *S* ≥ 0, *E* ≥ 0, *A* ≥ 0, *I* ≥ 0, *R* ≥ 0 and *V* ≥ 0.Fig. 2A model diagram of COVID-19 Dynamics.Fig. 2

2.1. Analysis on the model {#sec0003}
--------------------------

We simplify [Eq. (1)](#eq0001){ref-type="disp-formula"} to get the total differential equation as;$$\begin{array}{r}
\begin{cases}
\frac{dN}{dt} & {= \Lambda - \omega N - \alpha I,} \\
\frac{dV}{dt} & {= m_{1}A + m_{2}I - \tau_{1}V,} \\
\end{cases} \\
\end{array}$$where $N = S + E + A + I + R$.Theorem 1*The solution set* {*S*(*t*), *E*(*t*), *A*(*t*), *I*(*t*), *R*(*t*), *V*(*t*)} *is positive whenever the parameters are non-negative such that the initial conditions are also given as* $$\left\{ S\left( 0 \right) \geq 0,\, E\left( 0 \right) \geq 0,\, A\left( 0 \right) \geq 0,\, I\left( 0 \right) \geq 0,\, R\left( 0 \right) \geq 0,\, V\left( 0 \right) \geq 0 \right\},$$ *The proof of Theorem* [1](#enun0001){ref-type="statement"} *can be obtained using the procedures presented in* [@bib0033] *, as shown below.* ProofWe let $Y = \left( S,E,A,I,R,V \right)^{\mathcal{T}}$ and $K_{0} = \beta I,\, K_{1} = \beta A,\, K_{2} = \beta_{1}V$ where $\mathcal{T}$ is transposition, then our differential [Eq. (1)](#eq0001){ref-type="disp-formula"} can be rewritten in a matrix form as $\frac{dY}{dt} = MY + M_{1},$ where$$\begin{array}{cl}
 & {M = \begin{pmatrix}
{- \left( \omega + K_{0} + \eta K_{1} + K_{2} \right)} & 0 & 0 & 0 & \rho & 0 \\
\left( K_{0} + \eta K_{1} + K_{2} \right) & {- \left( K_{2}\left( 1 - \gamma \right) + k_{1}\gamma + \omega \right)} & 0 & 0 & 0 & 0 \\
0 & {k_{2}\left( 1 - \gamma \right)} & {- \left( \omega + v_{1}\phi + v_{2}\left( 1 - \gamma \right) \right)} & 0 & 0 & 0 \\
0 & {k_{1}\gamma} & {v_{1}\phi} & {- \left( \epsilon + \omega + \alpha \right)} & 0 & 0 \\
0 & 0 & {v_{2}\left( 1 - \phi \right)} & \epsilon & {- \left( \rho + \omega \right)} & 0 \\
0 & 0 & m_{1} & m_{2} & 0 & {- \tau_{1}} \\
\end{pmatrix},} \\
 & {M_{1} = \begin{pmatrix}
\Lambda \\
0 \\
0 \\
0 \\
0 \\
0 \\
\end{pmatrix}.} \\
\end{array}$$Now, using the third equation in model [(1)](#eq0001){ref-type="disp-formula"}, thus$$\frac{dA}{dt} = k_{2}\left( 1 - \gamma \right)E - \omega A - v_{1}\phi A - v_{2}\left( 1 - \phi \right)A,$$and deploying the method of integration factor and change of variables [@bib0033], yields$$\begin{array}{ccl}
{A\left( t \right)} & = & {A\left( 0 \right)e^{- (\omega + v_{1}\phi + v_{2}{(1 - \phi)})t} + e^{- (\omega + v_{1}\phi + v_{2}{(1 - \phi)})t}k_{2}\left( 1 - \gamma \right)} \\
 & & {\times \,\int_{0}^{t}E\left( s \right)e^{- (\omega + v_{1}\phi + v_{2}{(1 - \phi)})s}ds,} \\
 & = & {e^{- (\omega + v_{1}\phi + v_{2}{(1 - \phi)})t}\left\lbrack A\left( 0 \right) + k_{2}\left( 1 - \gamma \right)\int_{0}^{t}E\left( s \right)e^{- (\omega + v_{1}\phi + v_{2}{(1 - \phi)})s}ds \right\rbrack.} \\
\end{array}$$Next, we consider the fourth, fifth, sixth equation of model [(1)](#eq0001){ref-type="disp-formula"} and using the same above process, we have$$I\left( t \right) = e^{- (\epsilon + \omega + \alpha)t}\left\lbrack I\left( 0 \right) + v_{1}\phi\int_{0}^{t}A\left( s \right)e^{- (\epsilon + \omega + \alpha)s}ds + k_{1}\gamma\int_{0}^{t}E\left( s \right)e^{- (\epsilon + \omega + \alpha)s}ds \right\rbrack.$$ $$R\left( t \right) = e^{- (\rho + \omega)t}\left\lbrack R\left( 0 \right) + v_{2}\left( 1 - \phi \right)\int_{0}^{t}A\left( s \right)e^{- (\rho + \omega)s}ds + \epsilon\int_{0}^{t}I\left( s \right)e^{- (\rho + \omega)s}ds \right\rbrack.$$ $$V\left( t \right) = e^{- (\tau_{1})t}\left\lbrack V\left( 0 \right) + m_{1}\int_{0}^{t}A\left( s \right)e^{- (\tau_{1})s}ds + m_{2}\int_{0}^{t}I\left( s \right)e^{- (\tau_{1})s}ds \right\rbrack.$$Hence, from [@bib0034] and [@bib0035], we see that $\frac{dA}{dt}|_{t = t_{0}} \geq 0,$ $\frac{dI}{dt}|_{t = t_{0}} \geq 0,$ $\frac{dR}{dt}|_{t = t_{0}} \geq 0,$ $\frac{dV}{dt}|_{t = t_{0}} \geq 0,$ and $\frac{dE}{dt}|_{t = t_{0}} \geq 0,$ provided $E\left( t_{0} \right) = 0,$ with same ideas being valid for *S*(*t*), this guarantees that the state variable remain positive during the entire scope of the study [@bib0033]. Grounded on this, we can say that matrix *M* has all its off diagonal entries to be non-negative and that matrix *M* ~1~ ≥ 0, which proves the properties of Metzler matrix [@bib0033], [@bib0036]. Therefore it implies that model [(1)](#eq0001){ref-type="disp-formula"} is positively invariant in $\mathbb{R}_{+}^{6}$ [@bib0033]. For alternative proof to the above assertion see Atangana et al. [@bib0037]. □

2.2. Boundedness {#sec0004}
----------------

Theorem 2*The model of the system in Eq.* [(1)](#eq0001){ref-type="disp-formula"} *has solutions bounded within invariant region,* $\Omega \in \mathbb{R}^{6}$ *written as* $$\Omega = \left\{ \left( S,E,A,I,R,V \right) \in \mathbb{R}_{+}^{6}:N\left( t \right) \leq \frac{\Lambda}{\omega},\, V\left( t \right) \leq \frac{\Lambda m}{\omega\tau_{1}} \right\}.$$ *where* $m = \left( m_{1} + m_{2} \right).$ ProofFrom the first equation of [(2)](#eq0002){ref-type="disp-formula"} we have$$\frac{dN}{dt} \leq - \omega N + \Lambda.$$Now, take *M* ~2~ to be a solution which is unique to the initial value problem$$\left\{ \begin{array}{l}
{\frac{d}{dt}M_{2}\left( t \right) = \Lambda - \omega M_{2}\left( t \right)\,\,\,\text{for}\,\, t > 0,} \\
{M_{2}\left( 0 \right) = N\left( 0 \right).} \\
\end{array} \right.$$Which when solved gives$${M_{2}\left( t \right)}{= \frac{\Lambda}{\omega}\left( 1 - e^{( - \omega t)} \right) + N\left( 0 \right)e^{( - \omega t)}.}$$Hence, by the comparison principle (see for instant [Theorem 5](#enun0006){ref-type="statement"} of [@bib0038]), it accompanies that$${N\left( t \right)}{\leq \frac{\Lambda}{\omega}\left( 1 - e^{( - \omega t)} \right) + N\left( 0 \right)e^{( - \omega t)}.}$$Also from the second equation of [(2)](#eq0002){ref-type="disp-formula"}, we let $m = \left( m_{1} + m_{2} \right)$ with the assumption that $0 < A + I \leq \frac{\Lambda}{\omega}$. Then,$$\frac{\mathit{dV}}{\mathit{dt}} \leq \frac{m\Lambda}{\omega} - \tau_{1}V.$$Now, let *M* ~3~ to be a solution which is unique to the initial value problem$$\left\{ \begin{array}{l}
{\frac{d}{dt}M_{3}\left( t \right) = \frac{m\Lambda}{\omega} - \tau_{1}V\,\,\,\text{for}\,\, t > 0,} \\
{M_{3}\left( 0 \right) = V\left( 0 \right).} \\
\end{array} \right.$$Which when solved gives$${M_{3}\left( t \right)}{= \frac{m\Lambda}{\omega}\left( 1 - e^{( - \tau_{1}t)} \right) + V\left( 0 \right)e^{( - \tau\, t)},}$$and, by the comparison principle (see for instant [Theorem 5](#enun0006){ref-type="statement"} of [@bib0038]), it accompanies that$${V\left( t \right)}{\leq \frac{m\Lambda}{\omega}\left( 1 - e^{( - \tau\, t)} \right) + V\left( 0 \right)e^{( - \tau t)}.}$$From [(5)](#eq0005){ref-type="disp-formula"} and [(8)](#eq0008){ref-type="disp-formula"} it connotes that, all the possible solution sets of the state variables *S, E, A, I, R, V* is bounded and, by the blow-up phenomena, hence the solutions exist and is defined for all *t* ≥ 0 [@bib0038]. Furthermore, for $\left. t\rightarrow + \infty, \right.$ we get$$\begin{aligned}
0 & {\leq N\left( t \right) \leq \frac{\Lambda}{\omega},} \\
0 & {\leq V\left( t \right) \leq \frac{m\Lambda}{\omega\tau_{1}}.} \\
\end{aligned}$$This guarantees that, all the possible solution sets of the state variables *S, E, A, I, R, V* are contained in Ω making the model both mathematically and epidemiologically well posed (thus, model [(1)](#eq0001){ref-type="disp-formula"} is positively invariant). □

2.3. Disease free equilibrium point, $\mathcal{E}$ {#sec0005}
--------------------------------------------------

Here, we first focus on equilibrium points when there is no disease in the system. Considering [Eq. (1)](#eq0001){ref-type="disp-formula"}, we put $E = A = I = R = V = 0$. This indicates that, there is no disease in the system at this stage. Therefore, solving for the stationary points, we have $\mathcal{E} = \left( S^{*},0,0,0,0,0 \right)$ where $S^{*} = \frac{\Lambda}{\omega}.$

2.4. Basic reproductive number, $\mathcal{R}_{0}$ {#sec0006}
-------------------------------------------------

For the $\mathcal{R}_{0}$, we use the concept of the next generation approach. Here, we seek to find the average number of new infections given that an infected individual is introduced into the population under study [@bib0039]. We let *G* be the next generation matrix which consists of *f~i~*(*x*), $v_{i}^{+}\left( x \right)$ and $v_{i}^{-}\left( x \right),$ $i = 1,2,\ldots,n \in \mathbb{N}$; where *f~i~*(*x*) is the rate at which a new infection occurs in compartment *i*. Also, $v_{i}^{+}$ and $v_{i}^{-}$ are the rate of immigration into compartment *i* and the rate at which new individuals are transferred from compartment *i* respectively. We note that, all the functions are continuously differentiable at least twice [@bib0039]. Let$$F = \left\lbrack \frac{\partial f_{i}\left( x_{0} \right)}{\partial x_{i}} \right\rbrack\quad\text{and}\quad V = \left\lbrack \frac{\partial V_{i}\left( x_{0} \right)}{\partial x_{i}\left( x_{0} \right)} \right\rbrack,$$where $V_{i} = v_{i}^{-}\left( x \right) - v_{i}^{+}\left( x \right)$.

Now the next generation matrix is defined as;$$G = FV^{- 1}.$$Hence, the $\mathcal{R}_{0}$ is given as the maximum absolute eigenvalue of the next generation matrix (G) given that, *σ* contains all the eigenvalues of *G*. This eigenvalue is known as the spectral radius (*ρ*). This is represented as$$\rho\left( G \right) = \text{sup}\left\{ \middle| \lambda \middle| :\lambda \in \sigma\left( G \right) \right\}.$$Among the infected classes (E, A, I, V), we have *f~i~* as$$\begin{array}{r}
{f_{i} = \begin{bmatrix}
{\beta\left( AS + IS \right) + \beta_{1}VS} \\
0 \\
0 \\
0 \\
\end{bmatrix}.} \\
\end{array}$$Finding the Jacobian of the matrix *f~i~* gives$$\begin{aligned}
{F = \begin{bmatrix}
0 & {\eta\beta S} & {\beta S} & {\beta_{1}S} \\
0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 \\
\end{bmatrix}} & {= \begin{bmatrix}
0 & {\eta\beta\frac{\Lambda}{\omega}} & {\beta\frac{\Lambda}{\omega}} & {\beta_{1}\frac{\Lambda}{\omega}} \\
0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 \\
\end{bmatrix}.} \\
\end{aligned}$$Considering the same compartments (*E, A, I, V*), we get the matrix *V* as$$\begin{array}{r}
{V_{i} = \begin{bmatrix}
{k_{2}\left( 1 - \gamma \right)E + k_{1}\gamma E + \omega E} \\
{- k_{2}\left( 1 - \gamma \right)E + \omega A + v_{1}\phi A + v_{2}\left( 1 - \phi \right)A} \\
{- k_{1}\gamma E - v_{1}\phi A + \epsilon I + \left( \omega + \alpha \right)I} \\
{- m_{1}A - m_{2}I + \tau_{1}V} \\
\end{bmatrix}.} \\
\end{array}$$Finding the Jacobian matrix of *V~i~* gives$$\begin{array}{r}
{V = \begin{bmatrix}
{\gamma k_{1} + k_{2}\left( 1 - \gamma \right) + \omega} & 0 & 0 & 0 \\
{- k_{2}\left( 1 - \gamma \right)} & {\omega + \phi v_{1} + v_{2}\left( 1 - \phi \right)} & 0 & 0 \\
{- \gamma k_{1}} & {- \phi v_{1}} & {\alpha + \epsilon + \omega} & 0 \\
0 & {- m_{1}} & {- m_{2}} & \tau_{1} \\
\end{bmatrix}.} \\
\end{array}$$After computing for the eigenvalues of the matrix *G*, we have that the maximum absolute eigenvalue, $\mathcal{R}_{0}$ is given as;$$\begin{array}{cl}
\mathcal{R}_{0} & {= \underset{\text{secondary}\text{infection}\text{seeded}\text{by}\text{A}\text{state}\text{through}\text{direct}\text{contact}}{\underset{︸}{\frac{\beta\eta\Lambda\kappa_{2}\left( 1-\gamma \right)}{\omega\left( \kappa_{2}\left( 1-\gamma \right)+\kappa_{1}\gamma+\omega \right)\left( \omega+\nu_{1}\phi+\nu_{2}\left( 1-\phi \right) \right)}}}} \\
 & {\mspace{6mu} + \underset{\text{secondary}\text{infection}\text{seeded}\text{by}\text{I}\text{state}\text{through}\text{direct}\text{contact}}{\underset{︸}{\frac{\beta\Lambda\left\lbrack \left( \omega+\nu_{1}\phi+\nu_{2}\left( 1-\phi \right) \right)\kappa_{1}\gamma+\kappa_{2}\nu_{1}\left( 1-\gamma \right)\phi \right\rbrack}{\omega\left( \kappa_{2}\left( 1-\gamma \right)+\kappa_{1}\gamma+\omega \right)\left( \omega+\nu_{1}\phi+\nu_{2}\left( 1-\phi \right) \right)\left( \varepsilon+\omega+\alpha \right)}}}} \\
 & {\mspace{6mu} + \underset{\text{secondary}\text{infection}\text{seeded}\text{by}\text{A}\text{state}\text{through}\text{the}\text{environment}}{\underset{︸}{\frac{\beta_{1}m_{1}\Lambda\kappa_{2}\left( 1-\gamma \right)}{\omega\left( \kappa_{2}\left( 1-\gamma \right)+\kappa_{1}\gamma+\omega \right)\left( \omega+\nu_{1}\phi+\nu_{2}\left( 1-\phi \right) \right)\tau_{1}}}}} \\
 & {\mspace{6mu} + \underset{\text{secondary}\text{infection}\text{seeded}\text{by}\text{I}\text{state}\text{through}\text{the}\text{environment}}{\underset{︸}{\frac{\beta_{1}m_{2}\Lambda\left\lbrack \left( \omega+\nu_{1}\phi+\nu_{2}\left( 1-\phi \right) \right)\kappa_{1}\gamma+\kappa_{2}\nu_{1}\left( 1-\gamma \right)\phi \right\rbrack}{\omega\left( \kappa_{2}\left( 1-\gamma \right)+\kappa_{1}\gamma+\omega \right)\left( \omega+\nu_{1}\phi+\nu_{2}\left( 1-\phi \right) \right)\left( \varepsilon+\omega+\alpha \right)\tau_{1}},}}} \\
\end{array}$$which can be written as$$\mathcal{R}_{0}{= \mathcal{R}_{A} + \mathcal{R}_{I} + \mathcal{R}_{Ae} + \mathcal{R}_{Ie},}$$where $\mathcal{R}_{A}$ is the secondary infections generated by asymptomatic persons through direct contact; $\mathcal{R}_{I}$ is the secondary infections generated by symptomatic persons through direct contact; $\mathcal{R}_{Ae}$ is the secondary infection seeded by asymptomatic persons through the environment; and $\mathcal{R}_{Ie}$ is the secondary infection seeded by symptomatic persons through the environment. We can also express $\mathcal{R}_{0}$ in terms of (*T* ~1~, *C* ~1~, *Q* ~1~, *Y* ~1~, *X* ~1~) as;$$\mathcal{R}_{0} = \frac{\Lambda}{\omega T_{1}}\begin{bmatrix}
{\beta\left( \frac{C_{1}k_{1}\gamma\tau_{1} + X_{1}Y_{1}\eta\tau_{1} + X_{1}v_{1}\rho\tau_{1}}{\tau_{1}C_{1}Y_{1}} \right) + \beta_{1}\left( \frac{m_{1}Q_{1} + C_{1}k_{1}\gamma m_{2} + X_{1}m_{2}v_{1}\phi}{\tau_{1}C_{1}Y_{1}} \right)} \\
\end{bmatrix}.$$where $T_{1} = \gamma k_{1} + k_{2}\left( 1 - \gamma \right) + \omega,C_{1} = \omega + \phi v_{1} + v_{2}\left( 1 - \phi \right),Q_{1} = k_{2}\phi v_{1}\left( 1 - \gamma \right),Y_{1} = \alpha + \epsilon + \omega,X_{1} = k_{2}\left( 1 - \gamma \right).$

2.5. Endemic equilibrium point, $\mathcal{E}^{**}$ {#sec0007}
--------------------------------------------------

We let, $\mathcal{E}^{**},$ be the endemic equilibrium points. Considering [Eq. (1)](#eq0001){ref-type="disp-formula"}, we solve for the endemic equilibrium points $\mathcal{E}^{**} = \left\{ S^{**},E^{**},A^{**},I^{**},R^{**},V^{**} \right\}$ with an assumption that; at the endemic state, *E* ≠ 0, *A* ≠ 0, *I* ≠ 0, *R* ≠ 0, *V* ≠ 0. Hence, equating the derivatives of [Eq. (1)](#eq0001){ref-type="disp-formula"} to zero, yields$$\begin{aligned}
{\Lambda - \omega S - \beta\left( IS + \eta AS \right) - \beta_{1}VS + \rho R} & {= 0,} \\
{\beta\left( IS + \eta AS \right) + \beta_{1}VS - k_{2}\left( 1 - \gamma \right)E - k_{1}\gamma E - \omega E} & {= 0,} \\
{k_{2}\left( 1 - \gamma \right)E - \omega A - v_{1}\phi A - v_{2}\left( 1 - \phi \right)A} & {= 0,} \\
{k_{1}\gamma E + v_{1}\phi A - \epsilon I - \left( \omega + \alpha \right)I} & {= 0,} \\
{v_{2}\left( 1 - \phi \right)A + \epsilon I - \rho R - \omega R} & {= 0,} \\
{m_{1}A + m_{2}I - \tau_{1}V} & {= 0.} \\
\end{aligned}$$Now, expressing the other state variables in terms of *E*, it implies that$$\begin{array}{cl}
 & {A = \frac{X_{1}E}{C_{1}},} \\
 & {I = \frac{k_{1}\gamma E}{Y_{1}} + \frac{v_{1}Q_{1}E}{Y_{1}C_{1}},} \\
 & {R = \frac{v_{2}\left( 1 - \phi \right)X_{1}E}{\left( \rho + \omega \right)C_{1}} + \frac{\epsilon k_{1}\gamma E}{\left( \rho + \omega \right)Y_{1}} + \frac{Q_{1}E}{Y_{1}C_{1}},} \\
 & {V = \frac{m_{1}X_{1}E}{\tau_{1}C_{1}} + m_{2}\begin{bmatrix}
{\frac{k_{1}\gamma E}{Y_{1}\tau_{1}} + \frac{Q_{1}E}{Y_{1}C_{1}\tau_{1}}} \\
\end{bmatrix}.} \\
\end{array}$$We now substitute *A, I* and *V* into second [Eq. (12)](#eq0012){ref-type="disp-formula"} and factorizing *E* out gives$$\begin{bmatrix}
{\beta S\begin{bmatrix}
{\frac{k_{1}\gamma}{Y_{1}} + \frac{Q_{1}}{Y_{1}C_{1}} + \frac{\eta X_{1}}{C_{1}}} \\
\end{bmatrix} + \beta_{1}S\begin{bmatrix}
{\frac{m_{1}X_{1}}{\tau_{1}C_{1}} + m_{2}\begin{pmatrix}
{\frac{k_{1}\gamma}{Y_{1}\tau_{1}} + \frac{Q_{1}}{Y_{1}C_{1}\tau_{1}}} \\
\end{pmatrix}} \\
\end{bmatrix} - T_{1}} \\
\end{bmatrix}E = 0.$$From the initial hypothesis, *E* ≠ 0 and this implies that,$$\beta S^{*}\begin{bmatrix}
{\frac{k_{1}\gamma}{Y_{1}} + \frac{Q_{1}}{Y_{1}C_{1}} + \frac{\eta X_{1}}{C_{1}}} \\
\end{bmatrix} + \beta_{1}S^{*}\begin{bmatrix}
{\frac{m_{1}X_{1}}{\tau_{1}C_{1}} + m_{2}\begin{pmatrix}
{\frac{k_{1}\gamma}{Y_{1}\tau_{1}} + \frac{Q_{1}}{Y_{1}C_{1}\tau_{1}}} \\
\end{pmatrix}} \\
\end{bmatrix} - T_{1} = 0.$$Making *S*\* in [Eq. (14)](#eq0014){ref-type="disp-formula"} the subject gives$$S^{*} = \frac{T_{1}}{\beta\begin{bmatrix}
{\frac{k_{1}\gamma}{Y_{1}} + \frac{Q_{1}}{Y_{1}C_{1}} + \frac{\eta X_{1}}{C_{1}}} \\
\end{bmatrix} + \beta_{1}\begin{bmatrix}
{\frac{m_{1}X_{1}}{\tau_{1}C_{1}} + m_{2}\begin{pmatrix}
{\frac{k_{1}\gamma}{Y_{1}\tau_{1}} + \frac{Q_{1}}{Y_{1}C_{1}\tau_{1}}} \\
\end{pmatrix}} \\
\end{bmatrix}}.$$Now, adding first equation and second equation of [(12)](#eq0012){ref-type="disp-formula"}, we substitute *S*\* from [Eq. (15)](#eq0015){ref-type="disp-formula"} and simplify *E*\* we get$$E^{*} = \frac{T_{1}}{HL} - \frac{\Lambda}{L},$$where$$\begin{aligned}
H & {= \beta\begin{bmatrix}
{\frac{k_{1}\gamma}{Y_{1}} + \frac{Q_{1}}{Y_{1}C_{1}} + \frac{\eta X_{1}}{C_{1}}} \\
\end{bmatrix} + \beta_{1}\begin{bmatrix}
{\frac{m_{1}X_{1}}{\tau_{1}C_{1}} + m_{2}\begin{pmatrix}
{\frac{k_{1}\gamma}{Y_{1}\tau_{1}} + \frac{Q_{1}}{Y_{1}C_{1}\tau_{1}}} \\
\end{pmatrix}} \\
\end{bmatrix},} \\
L & {= \begin{bmatrix}
{\frac{\rho v_{2}\left( 1 - \phi \right)X_{1}}{\left( \rho + \omega \right)C_{1}} + \frac{\rho k_{1}\gamma\epsilon}{\left( \rho + \omega \right)Y_{1}} + \frac{\rho Q_{1}\epsilon}{\left( \rho + \omega \right)Y_{1}C_{1}} - T_{1}} \\
\end{bmatrix}.} \\
\end{aligned}$$But, we know that the basic reproduction number is expressed as$$\begin{array}{r}
{\mathcal{R}_{0} = \frac{\Lambda}{\omega T_{1}}\left\lbrack \begin{array}{l}
{\beta\left( \frac{C_{1}k_{1}\gamma\tau_{1} + X_{1}Y_{1}\eta\tau_{1} + X_{1}v_{1}\rho\tau_{1}}{\tau_{1}C_{1}Y_{1}} \right)} \\
{+ \beta_{1}\left( \frac{m_{1}Q_{1} + C_{1}k_{1}\gamma m_{2} + X_{1}m_{2}v_{1}\phi}{\tau_{1}C_{1}Y_{1}} \right)} \\
\end{array} \right\rbrack.} \\
\end{array}$$Therefore, we express the endemic equilibrium points, (*S*\*, *E*\*, *A*\*, *I*\*, *R*\*, *V*\*) in terms of $\mathcal{R}_{0}$ as;$$\begin{array}{ccl}
 & & {S^{**} = \frac{\Lambda}{\mathcal{R}_{0}\omega},A^{**} = g_{1}E^{**},I^{**} = g_{2}E^{**},} \\
 & & {R^{**} = g_{3}E^{**},V^{**} = \left( \frac{m_{1}X_{1}}{\tau_{1}C_{1}} + m_{2}\left( \frac{k_{1}\gamma}{Y_{1}\tau_{1}} + \frac{Q_{1}}{Y_{1}C_{1}\tau_{1}} \right) \right)E^{**},} \\
 & & {E^{**} = \frac{\Lambda}{\omega\left( g_{1} + \left( 1 - \alpha \right)g_{2} + g_{3} + 1 \right)}\left( 1 - \frac{1}{\mathcal{R}_{0}} \right).} \\
\end{array}$$where $g_{1} = \frac{X_{1}}{C_{1}},g_{2} = \left( \frac{k_{1}\gamma}{Y_{1}} + \frac{v_{1}Q_{1}}{Y_{1}C_{1}} \right),g_{3} = \left( \frac{v_{2}\left( 1 - \phi \right)X_{1}}{\left( \rho + \omega \right)C_{1}} + \frac{\epsilon k_{1}\gamma}{\left( \rho + \omega \right)Y_{1}} + \right.\left. \frac{Q_{1}}{Y_{1}C_{1}} \right)$. Therefore, the endemic equilibrium for the COVID-19 model remains positive if and only if $\mathcal{R}_{0} > 1,$ since at the endemic equilibrium, *E* \> 0, *R* \> 0, *I* \> 0, *A* \> 0. Fulfilling, that we have a unique endemic equilibrium point $\mathcal{E}^{**},$ when $\mathcal{R}_{0} > 1$. (see [@bib0040] for an alternative prove on unique endemic equilibrium point.

2.6. Global stability {#sec0008}
---------------------

We focus on the application of Lyapunov's function in this area. Lyapunov function is a scalar function which may be employed to ascertain global stability [@bib0041].Definition 1Let the equilibrium of $y^{\prime} = f\left( y \right)$ be *y*\* such that $\left. f:\mathbb{R}^{n}\mapsto\mathbb{R}^{n} \right.$. We define *L* to be a continuous scalar function, implying; $\left. L:\mathbb{R}^{n}\mapsto\mathbb{R} \right.$. If the conditions$$L\left( y^{*} \right) = 0,\quad L\left( y \right) > 0\quad\forall y \neq y^{*},$$are satisfied, then the function *L* is said to be positive definite. Also, a scalar function *L*(*y*) such that $\left. L:\mathbb{R}^{n}\mapsto\mathbb{R} \right.$ is called radially unbounded if *L*(*y*)↦∞ as \|\|*y*\|\|↦∞ [@bib0041].

Based on the preliminary notes above, we now state the Lyapunov stability theorem.Theorem 3Lyapunov Stability Theorem*The equilibrium, y*\* *is globally stable if the function, L*(*y*) *is radially unbounded and positive definite globally such that it has globally negative time derivative,* $$\overset{˙}{L}\left( y \right) < 0\quad\forall y \neq y^{*}.$$ *We say that; the function L*(*y*) *is a Lyapunov function if it satisfies the above theorem, the proof can be found in* [@bib0041] *.*

Another important theorem which also plays a key role here is the Kransovkii-LaSalle theorem. This is an extension of Lyapunov function. In summary, this theorem puts forward that; considering an autonomous system, $y^{\prime} = f\left( y \right)$ which has equilibrium, *y*\* and that $f\left( y^{*} \right) = 0,$ we assume there is a continuously differentiable positive definite and radially unbounded function $\left. L:\mathbb{R}^{n}\mapsto\mathbb{R} \right.$ which meets the condition $\overset{˙}{L}\left( y \right) \leq 0\,\forall\, t,$ $y \in \mathbb{R}^{n}$. We then define the invariant set as$$\zeta = \left\{ y \in \mathbb{R}^{n} \middle| \overset{˙}{L}\left( y \right) = 0 \right\}.$$From the set above, the equilibrium *y*\* is globally stable if *ζ* constitutes only the equilibrium *y*\* [@bib0041](a fractional prove of stability can be extracted from [@bib0042]).Theorem 4*The disease-free equilibrium point of the COVID-19 model is globally stable if* $\mathcal{R}_{0} < 1$ *.* ProofWe employ the approach in [@bib0043] to analyze both the stability at disease free and endemic equilibrium. We define a Lyapunov, *L* for the disease-free equilibrium point as follows;$$\begin{array}{ccl}
L & = & {E + \left( \frac{\beta\eta}{C_{1}} + \frac{\beta v_{1}\phi}{Y_{1}C_{1}} + \frac{\beta_{1}m_{2}v_{1}\phi}{Y_{1}\tau_{1}C_{1}} + \frac{\beta_{1}m_{1}}{C_{1}\tau_{1}} \right)A} \\
 & & {+ \left( \frac{\beta}{Y_{1}} + \frac{\beta_{1}m_{2}}{Y_{1}\tau_{1}} \right)I + \frac{\beta_{1}}{\tau_{1}}V.} \\
\end{array}$$Differentiating *L* with respect to *t* gives;$$\overset{˙}{L} = \overset{˙}{E} + \left( \frac{\beta\eta}{C_{1}} + \frac{\beta v_{1}\phi}{Y_{1}C_{1}} + \frac{\beta_{1}m_{2}v_{1}\phi}{Y_{1}\tau_{1}C_{1}} + \frac{\beta_{1}m_{1}}{C_{1}\tau_{1}} \right)\overset{˙}{A} + \left( \frac{\beta_{1}m_{2}}{Y_{1}\tau_{1}} \right)\overset{˙}{I} + \frac{\beta_{1}}{\tau_{1}}\overset{˙}{V}.$$We substitute $\overset{˙}{E},$ $\overset{˙}{A},$ $\overset{˙}{I},$ $\overset{˙}{V}$ from [Eq. (1)](#eq0001){ref-type="disp-formula"} into $\overset{˙}{L}$ gives;$$\begin{array}{ccl}
\overset{˙}{L} & = & {\beta\left( IS + \eta AS \right) + \beta_{1}VS - k_{2}\left( 1 - \gamma \right)E - k_{1}\gamma E - \omega E} \\
 & & {+ \left( \frac{\beta\eta}{C_{1}} + \frac{\beta v_{1}\phi}{Y_{1}C_{1}} + \frac{\beta_{1}m_{2}v_{1}\phi}{Y_{1}\tau_{1}C_{1}} + \frac{\beta_{1}m_{1}}{C_{1}\tau_{1}} \right)} \\
 & & {\times \left( k_{2}\left( 1 - \gamma \right)E - \omega A - v_{1}\phi A - v_{2}\left( 1 - \phi \right)A \right)} \\
 & & {+ \left( \frac{\beta}{Y_{1}} + \frac{\beta_{1}m_{2}}{Y_{1}\tau_{1}} \right)\left( k_{1}\gamma E + v_{1}\phi A - \epsilon I - \left( \omega + \alpha \right)I \right)} \\
 & & {+ \frac{\beta_{1}}{\tau_{1}}\left( m_{1}A + m_{2}I - \tau_{1}V \right).} \\
\end{array}$$After further simplification we have$$\begin{array}{cl}
\overset{˙}{L} & {= T_{1}\begin{bmatrix}
{\frac{\Lambda}{\omega T_{1}}\begin{bmatrix}
{\beta\left( \frac{\eta X_{1}}{C_{1}} + \frac{\gamma k_{1}}{Y_{1}} + \frac{Q_{1}}{Y_{1}C_{1}} \right) + \beta_{1}\left( \frac{m_{1}X_{1}}{\tau_{1}C_{1}} + \frac{m_{2}\gamma k_{1}}{\tau_{1}Y_{1}} + \frac{m_{2}Q_{1}}{\tau_{1}Y_{1}C_{1}} \right)} \\
\end{bmatrix} - 1} \\
\end{bmatrix}} \\
 & {= T_{1}\left( \mathcal{R}_{0} - 1 \right)E} \\
\end{array}$$Therefore, $\overset{˙}{L} \leq 0$ whenever $\mathcal{R}_{0} < 1$. Also, $\overset{˙}{L} = 0$ if and only if $E = A = I = V = 0$. We then define the invariant set as$$\zeta = \left\{ \left( E,A,I,V \right) \in \mathbb{R}^{n}:\overset{˙}{L}\left( y \right) = 0 \right\}.$$Hence, by the Krasovkii-LaSalle theorem, it follows that since *ζ* houses only the equilibrium $\mathcal{E}^{*},$ the $\mathcal{E}^{*}$ is said to be globally stable whenever $\mathcal{R}_{0} < 1$ [@bib0041]. □ Theorem 5*If* $\mathcal{R}_{0} > 1,$ *the endemic equilibrium point of the COVID-19 model is globally asymptotically stable in* Ω [@bib0044] *.* ProofSimilarly, to check for the global stability for the endemic equilibrium point, we define a Lyapunov function, *L* ~1~;$$\begin{array}{ccl}
L_{1} & = & {\left( S - S^{**} - S^{**}\ln\frac{S}{S^{**}} \right) + h_{1}\left( E - E^{*} - E^{**}\ln\frac{E}{E^{**}} \right)} \\
 & & {+ \, h_{2}\left( A - A^{**} - A^{**}\ln\frac{A}{A^{**}} \right) + h_{3}\left( I - I^{**} - I^{*}\ln\frac{I}{I^{*}} \right)} \\
 & & {+ \, h_{4}\left( R - R^{**} - R^{**}\ln\frac{R}{R^{**}} \right) + h_{5}\left( V - V^{**} - V^{**}\ln\frac{V}{V^{**}} \right).} \\
\end{array}$$Differentiating the function above gives;$$\begin{array}{cl}
{\overset{˙}{L}}_{1} & {= \left( 1 - \frac{S^{**}}{S} \right)\overset{˙}{S} + h_{1}\left( 1 - \frac{E^{**}}{E} \right)\overset{˙}{E} + h_{2}\left( 1 - \frac{A^{**}}{A} \right)\overset{˙}{A} + h_{3}\left( 1 - \frac{I^{**}}{I} \right)\overset{˙}{I}} \\
 & {+ h_{4}\left( 1 - \frac{R^{**}}{R} \right)\overset{˙}{R} + h_{5}\left( 1 - \frac{V^{**}}{V} \right)\overset{˙}{V}.} \\
\end{array}$$Substituting [Eq. (1)](#eq0001){ref-type="disp-formula"} into [Eq. (18)](#eq0018){ref-type="disp-formula"} with further simplification gives;$$\begin{array}{ccl}
\overset{˙}{L_{1}} & = & {- \omega\left( 1 - \frac{1}{x_{1}} \right){}^{2}S + \left( 1 - \frac{1}{x_{1}} + x_{4} - x_{4}x_{1} \right)\beta I^{**}S^{**}} \\
 & & {+ \left( 1 - \frac{1}{x_{1}} + x_{3} - x_{3}x_{1} \right)\beta\eta A^{**}S^{**}} \\
 & & {+ \left( 1 - \frac{1}{x_{1}} + x_{6} - x_{6}x_{1} \right)\beta_{1}V^{**}S^{**} + \left( 1 - \frac{1}{x_{1}} + x_{5} - \frac{x_{5}}{x_{1}} \right)\rho R^{**}} \\
 & & {+ \left( x_{1}x_{4} - x_{2} - \frac{x_{1}x_{4}}{x_{2}} + 1 \right)\beta I^{**}S^{**}h_{1}} \\
 & & {+ \left( x_{1}x_{3} - x_{2} - \frac{x_{1}x_{3}}{x_{2}} + 1 \right)\beta\eta A^{**}S^{**}h_{1}} \\
 & & {+ \left( x_{1}x_{6} - x_{2} - \frac{x_{1}x_{6}}{x_{2}} + 1 \right)\beta_{1}V^{**}S^{**}h_{1}} \\
 & & {+ \left( 1 + x_{2} - x_{3} - \frac{x_{2}}{x_{3}} \right)h_{2}k_{2}\left( 1 - \gamma \right)E^{**}} \\
 & & {+ \left( 1 + x_{2} - x_{4} - \frac{x_{2}}{x_{4}} \right)h_{3}k_{1}\gamma E^{**} + \left( 1 + x_{3} - x_{4} - \frac{x_{3}}{x_{4}} \right)h_{3}v_{1}\phi A^{**}} \\
 & & {+ \left( 1 + x_{3} - x_{5} - \frac{x_{3}}{x_{5}} \right)h_{4}v_{2}\left( 1 - \phi \right)A^{**}} \\
 & & {+ \left( 1 + x_{4} - x_{5} - \frac{x_{4}}{x_{5}} \right)\epsilon I^{**}h_{4}} \\
 & & {+ \left( 1 + x_{3} - x_{6} - \frac{x_{3}}{x_{6}} \right)h_{5}m_{1}A^{**} + \left( 1 + x_{4} - x_{6} - \frac{x_{4}}{x_{6}} \right)h_{5}m_{2}I^{**}} \\
\end{array}$$where $x_{1} = \frac{S}{S^{**}},$ $x_{2} = \frac{E}{E^{**}},$ $x_{3} = \frac{A}{A^{**}},$ $x_{4} = \frac{I}{I^{**}},$ $x_{5} = \frac{R}{R^{**}}$ and $x_{6} = \frac{V}{V^{**}}$. We let$${\overset{˙}{L}}_{1} = - \omega\left( 1 - \frac{1}{x_{1}} \right){}^{2}S + T\left( x_{1},x_{2},x_{3},x_{4},x_{5},x_{6} \right),$$where$$\begin{array}{ccl}
T & = & {\beta I^{**}S^{**} + \beta\eta A^{**}S^{**} + \beta_{1}V^{**}S^{**} + \rho R^{**} + \beta I^{**}S^{**}h_{1}} \\
 & & {+ \beta\eta A^{**}S^{**}h_{1} + h_{2}k_{2}\left( 1 - \gamma \right)E^{**} + h_{3}k_{1}\gamma E^{**}} \\
 & & {+ h_{3}v_{1}\phi A^{**} + \beta_{1}V^{**}S^{**}h_{1} + h_{4}v_{2}\left( 1 - \phi \right)A^{**} + \epsilon I^{*}h_{4}} \\
 & & {+ h_{5}m_{1}A^{**} + h_{5}m_{2}I^{**}} \\
 & & {+ \left( - \beta I^{**}S^{**} - \beta\eta A^{**}S^{**} - \beta_{1}V^{**}S^{**} - \rho R^{**} \right)\frac{1}{x_{1}}} \\
 & & {+ \left( - \beta I^{**}S^{**}h_{1} - \beta\eta A^{**}S^{**}h_{1} - \beta_{1}V^{**}S^{**}h_{1} + h_{3}k_{1}\gamma E^{*} \right)x_{2}} \\
 & & {+ \left( \beta\eta A^{**}S^{**} - h_{2}k_{2}\left( 1 - \gamma \right)E^{**} + h_{3}v_{1}\phi A^{*} + h_{4}v_{2}\left( 1 - \phi \right)A^{**} \right.} \\
 & & {\left. \quad + h_{5}m_{1}A^{**} \right)x_{3}} \\
 & & {+ \left( \beta I^{**}S^{**} - h_{3}k_{1}\gamma E^{**} - h_{3}v_{1}\phi A^{**} + \epsilon I^{*}h_{4} + h_{5}m_{2}I^{*} \right)x_{4}} \\
 & & {+ \left( \rho R^{**} - h_{4}v_{2}\left( 1 - \phi \right)A^{**} - \epsilon I^{**}h_{4} \right)x_{5}} \\
 & & {+ \left( - h_{5}m_{1}A^{**} - h_{5}m_{2}I^{**} + \beta_{1}V^{**}S^{**} \right)x_{6}} \\
 & & {+ \left( - \beta I^{**}S^{**} + \beta I^{**}S^{**}h_{1} \right)x_{4}x_{1}} \\
 & & {+ \left( - \beta\eta A^{**}S^{**} + \beta\eta A^{**}S^{**}h_{1} \right)x_{3}x_{1}} \\
 & & {+ \left( - \beta_{1}V^{**}S^{**} + \beta_{1}V^{**}S^{**}h_{1} \right)x_{6}x_{1}} \\
 & & {- \rho R^{**}\frac{x_{5}}{x_{1}} - \beta I^{**}S^{**}h_{1}\frac{x_{1}x_{4}}{x_{2}} - \beta\eta A^{**}S^{**}h_{1}\frac{x_{3}x_{1}}{x_{2}}} \\
 & & {- \beta_{1}V^{**}S^{**}h_{1}\frac{x_{6}x_{1}}{x_{2}} - h_{2}k_{2}\left( 1 - \gamma \right)E^{*}\frac{x_{2}}{x_{3}}} \\
 & & {- h_{3}k_{1}\gamma E^{**}\frac{x_{2}}{x_{4}} - h_{3}v_{1}\phi A^{**}\frac{x_{3}}{x_{4}} - h_{4}v_{2}\left( 1 - \phi \right)A^{**}\frac{x_{3}}{x_{5}}} \\
 & & {- \epsilon I^{**}h_{4}\frac{x_{4}}{x_{5}} - h_{5}m_{1}A^{**}\frac{x_{3}}{x_{6}} - h_{5}m_{2}I^{**}\frac{x_{4}}{x_{6}}.} \\
\end{array}$$Considering the expression$$\beta I^{**}S^{**}h_{1} = \beta I^{**}S^{**},$$we have that, $h_{1} = 1$. This implies that the coefficients of *x* ~1~ *x* ~4~, *x* ~3~ *x* ~1~ and *x* ~6~ *x* ~1~ are all 0. Equating the coefficients of *x* ~2~, *x* ~3~, *x* ~4~, *x* ~5~ and *x* ~6~ to 0 and solving for *h* ~2~, *h* ~3~, *h* ~4~ and *h* ~5~ gives;$$\begin{array}{cl}
h_{2} & {= \frac{\beta\eta A^{**}S^{**}}{k_{2}\left( 1 - \gamma \right)E^{**}} + \frac{\left( \beta I^{**}S^{**} + \beta\eta A^{**}S^{**} + \beta_{1}V^{**}S^{**} \right)v_{1}\phi A^{**}}{k_{1}\gamma E^{**}k_{2}\left( 1 - \gamma \right)E^{**}}} \\
 & {+ \frac{v_{2}\left( 1 - \phi \right)A^{*}\rho R^{**}}{\left( v_{2}\left( 1 - \phi \right)A^{**} + \epsilon I^{**} \right)k_{2}\left( 1 - \gamma \right)E^{**}} + \frac{m_{1}A^{**}\beta_{1}V^{**}S^{**}}{\left( m_{1}A^{**} + m_{2}I^{**} \right)k_{2}\left( 1 - \gamma \right)E^{**}},} \\
h_{3} & {= \frac{\beta I^{**}S^{**} + \beta\eta A^{**}S^{**} + \beta_{1}V^{**}S^{**}}{k_{1}\gamma E^{**}},} \\
h_{4} & {= \frac{\rho R^{**}}{v_{2}\left( 1 - \phi \right)A^{**} + \epsilon I^{**}},} \\
h_{5} & {= \frac{\beta_{1}V^{**}S^{**}}{m_{1}A^{**} + m_{2}I^{**}}.} \\
\end{array}$$Therefore, *T* can be rewritten as$$\begin{array}{ccl}
T & = & {- \beta I^{**}S^{**}\left( x_{2} - x_{4} + \frac{1}{x_{1}} + \frac{x_{1}x_{4}}{x_{2}} - 2 \right)} \\
 & & {- \beta\eta A^{**}S^{**}\left( x_{2} - x_{3} + \frac{1}{x_{1}} + \frac{x_{3}x_{1}}{x_{2}} - 2 \right)} \\
 & & {- \beta_{1}V^{**}S^{**}\left( x_{2} - x_{6} + \frac{1}{x_{1}} + \frac{x_{1}x_{6}}{x_{2}} - 2 \right) - \rho R^{**}\left( - 1 + \frac{1}{x_{1}} - x_{5} + \frac{x_{5}}{x_{1}} - 2 \right)} \\
 & & {- h_{2}k_{2}\left( 1 - \gamma \right)E^{**}\left( x_{3} - 1 - x_{2} + \frac{x_{2}}{x_{3}} \right) - h_{3}k_{1}\gamma E^{**}\left( x_{4} - 1 - x_{2} + \frac{x_{2}}{x_{4}} \right)} \\
 & & {- h_{3}v_{1}\phi A^{**}\left( x_{4} - 1 - x_{3} + \frac{x_{3}}{x_{4}} \right) - h_{4}v_{2}\left( 1 - \phi \right)A^{**}\left( x_{5} - 1 - x_{3} + \frac{x_{3}}{x_{5}} \right)} \\
 & & {- \epsilon I^{**}h_{4}\left( x_{5} - 1 - x_{4} + \frac{x_{4}}{x_{5}} \right) - h_{5}m_{1}A^{**}\left( x_{6} - 1 - x_{3} + \frac{x_{3}}{x_{6}} \right)} \\
 & & {- h_{5}m_{2}I^{**}\left( x_{6} - 1 - x_{4} + \frac{x_{4}}{x_{6}} \right).} \\
\end{array}$$It then follows that, *T* ≤ 0 if $x_{1} = 1,$ $x_{2} = 1,$ $x_{3} = 1,$ $x_{4} = 1,$ $x_{5} = 1$ and $x_{6} = 1$. Hence we may conclude that;$${\overset{˙}{L}}_{1} = - \omega\left( 1 - \frac{1}{x_{1}} \right){}^{2}S + T\left( x_{1},x_{2},x_{3},x_{4},x_{5},x_{6} \right) \leq 0.$$By LaSalle theorem, the invariant set is defined as$$\zeta_{1} = \left\{ \left( S,E,A,I,R,V \right) \in D:L_{1} = 0 \right\}.$$Since the invariant set, *ζ* ~1~ only contains the endemic equilibrium (*S* ^⁎⁎^, *E* ^⁎⁎^, *A* ^⁎⁎^, *I* ^⁎⁎^, *R* ^⁎⁎^, *V* ^⁎⁎^), then the endemic equilibrium is said to be globally asymptotically stable under the given region Ω. □

3. Parameter estimation and numerical simulations {#sec0009}
=================================================

In this section, our focus is to verify the validity of the model. This is achieved by fitting and comparing the proposed model with a real data to know its degree of accuracy. This will justify the model's competency on predicting for a realistic outcome. Considering Ghana as a case study, the cumulative daily reported cases of COVID-19 were extracted from the situation reports of the WHO and the Ministry of Health, Ghana [@bib0011]. The collected data ranges from the onset of the pandemic in Ghana; that is from 12th March to 7th May, 2020. As of 7th May, 2020, 4012 cases were confirmed with 18 deaths and 323 recovered individuals. No clear detail was given with respect to the relapse of the recovered individuals into the susceptible class though this study factored. Estimating parameter values is very key as far as epidemiological study is concerned. We utilize the least squares method in this context since it is very efficient and reliable [@bib0041]. This method seeks to fit the observed data sets, *Y~i~*, with the estimated values, *X~i~*, such that; the sum of squares of errors between the observed and fitted curve is minimal [@bib0041]. The sum of squares error, *SSE*, is illustrated mathematically as;$$SSE = \sum\limits_{i = 1}^{k}\left( Y_{i} - X_{i} \right)^{2}.$$ [Table Appendix A](#sec0016){ref-type="sec"} account for the daily recorded cases and daily percentage change in the number of recorded cases.

The estimated parameter values and the fitted model using Python programming language are shown in [Table 2](#tbl0002){ref-type="table"} and [Fig. 3](#fig0003){ref-type="fig"} respectively. The blue points in [Fig. 3](#fig0003){ref-type="fig"} represent the cumulative number of daily confirmed cases while the red line designates the fitted model. From the estimated parameter values in [Table 2](#tbl0002){ref-type="table"}, it is clear that; even if all the infected individuals are treated, the susceptible class is still vulnerable to be infected since the rate at which the environment contribute to infection, *β* ~1~, is significant, thus 4.00199$\times 10^{- 8}$. Based on the estimated value for *γ*, only 1% of the exposed individuals join the infected compartment without passing through the asymptomatic state. Again, only 0.5% of the individuals in the asymptomatic class join the symptomatic class at the rate of 0.2 per day while the rest of the asymptomatic populace recover at the rate of 0.799994 per day.Table 2Estimated parameter values for the COVID-19 model [(1)](#eq0001){ref-type="disp-formula"}.Table 2ParameterRangeBaseline valueReference*η*$0.62811041 - 0.6366\text{day}^{- 1}$0.6323Estimated*ω*$0.000042578\,\text{day}^{- 1}$0.000042578[@bib0011]*ρ*$0.41138431\,\text{day}^{- 1}$0.41138431Estimated*β*$6.038 \times 10^{- 8} - 0.8038$$6.038 \times 10^{- 8}$Estimated*γ*$0.01000 - 0.0648$0.0374Estimated*β*~1~$4.00199 \times 10^{- 8}$$4.00199 \times 10^{- 8}$EstimatedΛ$1319.294\,\text{day}^{- 1}$1319.294[@bib0045], [@bib0046]*k*~1~$0.1923000 - 0.07142238\,\text{day}^{- 1}$0.1318Estimated*k*~2~$0.176300 - 0.14285824\,\text{day}^{- 1}$0.1596Estimated*α*$0.0044 - 0.0099\,\text{day}^{- 1}$0.0072Estimated*ϕ*0.005000050.0050Estimated*v*~1~$0.1929 - 0.2000\,\text{day}^{- 1}$0.1965Estimated*v*~2~$0.79999398\,\text{day}^{- 1}$0.8000Estimatedϵ$0.0805084 - 0.098026529\,\text{day}^{- 1}$0.0893[@bib0011]*τ*~1~$0.29000 - 0.3333\,\text{day}^{- 1}$0.3117[@bib0047]*m*~1~$0.01780400\,\text{day}^{- 1}$0.0178Estimated*m*~2~$0.92152716\,\text{day}^{- 1}$0.9215EstimatedFig. 3Fitted diagram of confirmed cases in Ghana and the proposed model.Fig. 3

3.1. Basic reproduction number, $\mathcal{R}_{0}$ with no control {#sec0010}
-----------------------------------------------------------------

Our main objective here is to compute the basic reproduction number of the model [(1)](#eq0001){ref-type="disp-formula"}. Using the values $\eta = 0.62811041,\omega = 0.000042578,\rho = 0.41138431,\beta = 6.038 \times 10^{- 8},\beta_{1} = 4.00199 \times 10^{- 8},\gamma = 0.01000001,\Lambda = 1319.294,\mspace{6mu} k_{1} = 0.07142238,k_{2} = 0.14285824,\alpha = 0.00440000,\phi = 0.00500005,v_{1} = 0.20005051,v_{2} = 0.79999398,\mspace{6mu}\epsilon = 0.0805840,\tau_{1} = 0.2900000,m_{1} = 0.01780400,m_{2} = 0.92152716,$ and substituting it into the $\mathcal{R}_{0}$ expression result in;$$\begin{array}{cl}
\mathcal{R}_{0} & {= \frac{\Lambda}{\omega T_{1}}\begin{bmatrix}
{\beta\left( \frac{C_{1}k_{1}\gamma\tau_{1} + X_{1}Y_{1}\eta\tau_{1} + X_{1}v_{1}\rho\tau_{1}}{\tau_{1}C_{1}Y_{1}} \right) + \beta_{1}\left( \frac{m_{1}Q_{1} + C_{1}k_{1}\gamma m_{2} + X_{1}m_{2}v_{1}\phi}{\tau_{1}C_{1}Y_{1}} \right)} \\
\end{bmatrix}} \\
 & {= \frac{1319.294}{4.2578 \times 10^{- 5} \times \left( 0.1421865 \right)}\left( 7.3634285 \times 10^{- 9} + 1.7708567 \times 10^{- 9} \right)} \\
 & {= 1.99,} \\
\end{array}$$where $T_{1} = 0.14218646,$ $C_{1} = 0.7970368,$ $Q_{1} = 0.0001415,$ $Y_{1} = 0.0849510,$ $X_{1} = 0.1414297$. However, using the baseline values in [Table 2](#tbl0002){ref-type="table"} and substituting it into the $\mathcal{R}_{0}$ expression result in;$$\begin{array}{cl}
\mathcal{R}_{0} & {= \frac{1319.294}{4.2578 \times 10^{- 5} \times \left( 0.15860 \right)}\left( 1.05604 \times 10^{- 8} + 6.71352 \times 10^{- 9} \right)} \\
 & {= 3.37,} \\
\end{array}$$where $T_{1} = 0.15860,$ $C_{1} = 0.79703,$ $Q_{1} = 0.00015,$ $Y_{1} = 0.09654,$ $X_{1} = 0.15363$. Therefore, the average basic reproduction number, $\mathcal{R}_{0}^{a},$ without control strategies in Ghana is approximately 2.68. This indicates that on average a single infected individual can spread the disease to 2 to 3 susceptible individuals. Hence, strengthening prophylaxis such as social distancing, wearing of nose masks, regular hand washing with soap and contact tracing, will highly perturb the key parameters aiding the spread of the disease. Suppose that, the implementation of these measures decreases the estimated values of *η, β* and *β* ~1~ to 0.32811041, $4.038 \times 10^{- 8}$ and $2.00199 \times 10^{- 8}$ respectively, then the basic reproduction number with these control outcomes will be given as 0.79774. This shows how effective these control measures are in COVID-19 battle field.

3.2. Sensitivity analysis {#sec0011}
-------------------------

Varying estimated parameter values might give different output as seen in [3.1](#sec0010){ref-type="sec"} and it is on this note that, we want to explore parameters which significantly influence the end results of the model under study. This concept is very important since it discusses and informs us about the most relevant factors to deal with so as to minimize the spread of COVID-19.Definition 2The parameter, *p* is said to be sensitive if any small alteration on *p* causes a significant change in the solution. It is worthy to note that, the parameter *p* is termed to be locally sensitive if the change in the value of parameter *p* influences the output of the model. In the same way, global sensitivity takes into account the overall change in the model output as a result of the change in all parameter values within their respective range [@bib0041].

In computing for the normalized sensitivity index ($\epsilon_{\mathcal{R}_{0}}^{p}$) on the $\mathcal{R}_{0}$ for each of the parameters *p*, we use the formulae below [@bib0041];$$\epsilon_{\mathcal{R}_{0}}^{p} = \frac{\partial\mathcal{R}_{0}}{\partial p}\frac{p}{\mathcal{R}_{0}}.$$Applying the formula above gives the parameters with their sensitivity index in the [Table 3](#tbl0003){ref-type="table"} .Table 3Normalized sensitivity index for each parameter for the COVID-19 model [(1)](#eq0001){ref-type="disp-formula"}.Table 3ParameterDescriptionSensitivity Index*η*Relative transmissibility by asymptomatic individuals$+ 0.7367$*ω*Natural death rate-1.0005*β*Transmission rate by asymptomatic and symptomatic individuals$+ 0.8060$*β*~1~Environmental transmission$+ 0.1939$*γ*Proportion of individuals who are timely diagnosis$+ 0.1693$ΛRecruitment rate$+ 1.0000$*k*~1~Progression rate from exposed to the symptomatic class$+ 0.1676$*k*~2~Progression rate from exposed to the asymptomatic class$- 0.1673$*α*Disease induced death rate$- 0.0112$*ϕ*Proportion of A patients who later move to the I class$+ 0.0460$*v*~1~Progression from asymptomatic to the symptomatic class$+ 0.0419$*v*~2~Progression from asymptomatic to the recovered class$- 0.8263$ϵThe rate at which symptomatic patients are recovered$- 0.2043$*τ*~1~Natural decay rate of virus from the environment (Surfaces)$- 0.1939$*m*~1~The rate of viral release into the environment by asymptomatic patients$+ 0.0477$*m*~2~The rate at which I patients release virus into the environment$+ 0.1461$

From [Table 3](#tbl0003){ref-type="table"}, all parameters with positive values, *η, β, β* ~1~, *γ*, Λ, *k* ~1~, *ϕ, v* ~1~, *m* ~1~ and *m* ~2~ indicate the increase in transmission of COVID-19 in the population in accordance to an increase in these parameter values. Prominent among these are Λ, *β* and *η*. On the other hand, parameters with negative sensitivity index, *ω, k* ~2~, *α, v* ~2~, ϵ and *τ* ~1~ indicate the decrease in the spread of COVID-19 for each unit increase in these parameters. Exploiting sensitivity analysis on this study enlightens policy makers on where to put more efforts in the fight against COVID-19. For example, the sensitivity index of Λ on $\mathcal{R}_{0}$ is 1. This implies that, a 1% change in the value of Λ will cause a corresponding increase in $\mathcal{R}_{0}$ by 1%. In the same manner, a 1% change in *β* increases the number of secondary infections by 0.8%. From the global sensitivity analysis as shown in [Fig. 4](#fig0004){ref-type="fig"} , it is clear that, fortifying measures which will aid in accelerating ϵ, *γ* and *τ* ~1~ will reduce the $\mathcal{R}_{0}$. These measures may include fumigating the environment (surfaces) especially in crowded areas such as markets and essential service providing institutions like banks, police stations and hospitals. Regular disinfecting of the transport systems would also increase the virus diminishing rate from the system, enhancing the outcome of the control reproductive number. Though, *ω* contributes significantly towards the reduction in the $\mathcal{R}_{0},$ but it is not considered as good candidate to be used as a control variable. This is grounded on the fact that, *ω*, is the natural death rate of the population of which we do not have much dominance.Fig. 4Global sensitivity plot .Fig. 4

In the same setting as illustrated in [Fig. 4](#fig0004){ref-type="fig"}, the parameters *m* ~2~, *m* ~1~, *k* ~2~, Λ, *β* ~1~, *β, η* prove to be more influential in increasing the reproduction number after performing the global sensitivity analysis. This is backed by the results in [Figs. 5](#fig0005){ref-type="fig"} , [6](#fig0006){ref-type="fig"} , [7](#fig0007){ref-type="fig"} and [Fig. 8](#fig0008){ref-type="fig"} where the effects of *β, β* ~1~, *m* ~1~, *m* ~2~, *η* and *ρ* on the infected population are explored. From the [Fig. 5](#fig0005){ref-type="fig"}a, [5](#fig0005){ref-type="fig"} b, [6](#fig0006){ref-type="fig"} a, [6](#fig0006){ref-type="fig"} b, [7](#fig0007){ref-type="fig"} a, [7](#fig0007){ref-type="fig"} b, [8](#fig0008){ref-type="fig"} a, [8](#fig0008){ref-type="fig"} b, we have a confirmation that, the number of the infected individuals increase as the parameters, *β, β* ~1~, *m* ~1~, *m* ~2~, *η* and *ρ* increase. So, does the recruitment rate, Λ. Therefore, the government's decision on travel restriction has really been of help to the country against the spread of the disease since this contributed massively to reduce the secondary infections which might have been contracted as a result of individuals from highly infected countries. Also, the analysis figures out that, mass testing and proper observance of social distancing with its complementary measures would far help in this fight. This analysis also establishes the fact that; adapting to healthy living/lifestyle which seek to boost the immune system such as proper dietary habit and abstinence from alcohol would significantly increase the number of individuals in the recovery compartment. One key feature which needs much attention is the rate at which viruses are released into the environment. This rate is very high among the asymptomatic patients, see [Fig. 4](#fig0004){ref-type="fig"}. This can be attributed to the fact that; since individuals in this class are mostly unaware about their contraction of COVID-19, strict measures against the virus' propagation is not properly observed among individuals in this class contributing to this effect. [Fig. 5](#fig0005){ref-type="fig"}a, is the simulation of the situation as of 7th May, 2020. Here, the basic reproduction number, $\mathcal{R}_{0}$ is 1.99. The graph confirms this figure that, if no effective control measures are employed, then this disease would continue to be experienced in the population for all time until the population gets diminished. [Fig. 5](#fig0005){ref-type="fig"}b describes the projections of the infected and asymptomatic individuals with no control measure for about two years period. It clearly depicts that, the number of individuals in the asymptomatic compartment far exceeds that of the infected class even as time transcends. This confirms the results of the parameter estimates that, only 1% of all the exposed individuals branch into the symptomatic class at the rate of 0.1676 while the rest move to the asymptomatic class. The model shows that, asymptomatic individuals can join the severely infected class. However, the estimated parameter value shows that, only few people experience such situation, that is, 0.5%.Fig. 5The dynamics of COVID-19 in Ghana considering the impact of the environment.Fig. 5Fig. 6The effects of varying *β, β*~1~ on the infected population.Fig. 6Fig. 7The effects of varying *m*~1~ and *m*~2~ on the infected population.Fig. 7Fig. 8The effects of *η* and *ρ* on the infected population.Fig. 8

Though, not much had been said with regards to the possibility of the recovered individuals joining the susceptible population. Notwithstanding, after our model's fitting, it was shown that, this situation might be possible at the rate of $0.41138\,\text{day}^{- 1}$ as shown in [Fig. 8](#fig0008){ref-type="fig"}b. This calls attention that, treatment must be geared towards provision of long term or permanent immunity so as to break the path between the recovered class and reinfection.

4. Optimal control on the model {#sec0012}
===============================

Considering the system $x^{\prime}\left( t \right) = f\left( x\left( t \right) \right)$ with $x\left( 0 \right) = x_{0},$ such that $x_{0} \in \mathbb{R}^{n}$ where $\left. f:\mathbb{R}^{n}\rightarrow\mathbb{R}^{n} \right.$ and $\left. x:\left\lbrack 0,\infty \right)\rightarrow\mathbb{R}^{n} \right.$. We introduce variables responsible for the control *u~i~*, $i = 1,2,3\ldots n \in \mathbb{N}$. We then have;$$x^{\prime}\left( t \right) = f\left( x\left( t \right),u\left( t \right) \right),\,\, x\left( 0 \right) = x_{0},$$with $\left. u:\left\lbrack 0,\infty \right)\rightarrow A \subset \mathbb{R}^{n} \right.$. The admissible control set is given as; $U^{*} = \left\{ u\left( t \right) \in L^{\prime}\left( t_{0},t_{f} \right) \middle| u\left( t \right) \in A \right\}.$ The aim here is to target the best control variables, *u~i~*, which can efficiently reduce the rate of secondary transmission at a minimum cost of their implementation at any time *t* ~(0)~ ≤ *t* ≤ *t* ~(*f*)~ [@bib0041]. That is, we seek to achieve a reduction in the number of individuals in the susceptible, exposed, asymptomatic, severely infected classes and also reduce the content of the virus in the system at a minimum cost simultaneously. To achieve the above objective demands a lot of constructive considerations. For example, implementing total lock down for about two months as a control strategy in this context might highly prove not to be feasible. The loop hole here is; is the country adequately prepared both financially and technically to provide to the satisfaction of its inhabitants the basic needs such as food, water and others throughout the whole period assigned for this measure? It is highly probable the answer might be a big no. It is an undeniable fact that, this measure might prove impractical in controlling the spread in this country. This is why there is a need to objectively sort for more dense restrictive measures with flexible and feasible approaches to be employed in this setting so as to control the disease. We rely on the Pontryagin's maximum principle as applied in [@bib0048] for this analysis. We base on the premises above to set below likely control strategies:1.$u_{1} =$ The effective testing and quarantine when boarders are opened.2.$u_{2} =$ Intensifying the usage of nose masks and face shields through education.3.$u_{3} =$ Cleaning of surfaces with home-based detergents.4.$u_{4} =$ Safety measures adopted by the asymptomatic and symptomatic individuals such as; practising proper cough etiquette (maintaining a distance, cover coughs and sneezes with disposable tissues or clothing and wash hands after cough or sneezes).5.$u_{5} =$ Fumigating commercial areas such as markets.

The objective functional under discussion, *Q*, which is to be minimized is given as;$$\begin{array}{ccl}
 & & {Q\left( u_{1},u_{2},u_{3},u_{4},u_{5} \right) = \text{min}\int_{t_{0}}^{t_{f}}} \\
 & & {\quad \times \left\lbrack E + A + I + V + \frac{b_{1}}{2}u_{1}^{2} + \frac{b_{2}}{2}u_{2}^{2} + \frac{b_{3}}{2}u_{3}^{2} + \frac{b_{4}}{2}u_{4}^{2} + \frac{b_{5}}{2}u_{5}^{2} \right\rbrack dt;} \\
\end{array}$$

subject to the constraints;$$\begin{array}{ccl}
\frac{dS}{dt} & = & {\left( 1 - u_{1} \right)\Lambda - \omega S - \left( 1 - u_{2} \right)\beta\left( IS + \eta AS \right) - \left( 1 - u_{2} - u_{3} \right)\beta_{1}VS,} \\
\frac{dE}{dt} & = & {\left( 1 - u_{2} \right)\beta\left( IS + \eta AS \right) + \left( 1 - u_{2} - u_{3} \right)\beta_{1}VS - k_{1}\gamma E} \\
 & & {- k_{2}\left( 1 - \gamma \right)E - \omega E,} \\
\frac{dA}{dt} & = & {k_{2}\left( 1 - \gamma \right)E - \omega A - v_{1}\phi A - v_{2}\left( 1 - \phi \right)A,} \\
\frac{dI}{dt} & = & {k_{1}\gamma E + v_{1}\phi A - \epsilon I - \left( \omega + \alpha \right)I,} \\
\frac{dR}{dt} & = & {v_{2}\left( 1 - \phi \right)A + \epsilon I - \omega R,} \\
\frac{dV}{dt} & = & {\left( 1 - u_{4} \right)m_{1}A + \left( 1 - u_{4} \right)m_{2}I - \left( u_{5} + \tau_{1} \right)V.} \\
\end{array}$$Where, *S* \> 0, *E* ≥ 0, *A* ≥ 0, *I* ≥ 0, *R* ≥ 0, *V* ≥ 0. From [Eq. (19)](#eq0019){ref-type="disp-formula"}, we assume that, the weight constant of the exposed, infected (*A* and *I* classes) and the virus in the system is 1. Also, to better observe and understand the influence of these control strategies on the model, we assumed that; no recovered individual is vulnerable to be reinfected in [Eq. (20)](#eq0020){ref-type="disp-formula"}. We accounted for the respective affiliated costs, $b_{1}u_{1}^{2},$ $b_{2}u_{2}^{2},$ $b_{3}u_{3}^{2},$ $b_{4}u_{4}^{2},$ $b_{5}u_{5}^{2},$ which are possible to be incurred during implementation where the square denotes their severity.

It is very necessary to ensure that, the proposed optimal solution exists. For this reason, we employ Filippove-Cesari theorem as used in [@bib0037]. In this case, we show that, the existence of the optimal control solution is guaranteed if the following conditions are satisfied;1.The admissible control set is compact and bounded.2.The control sets together with the state variables is non-empty.3.A linear function in the state and control variables bound the state systems of differential equations.4.The convexity of the integrand of cost functional with respect to *u* on the set *A* [@bib0037].

We now have the Hessian matrix of the given cost functional as;$$\begin{array}{r}
\begin{bmatrix}
b_{1} & 0 & 0 & 0 & 0 \\
0 & b_{2} & 0 & 0 & 0 \\
0 & 0 & b_{3} & 0 & 0 \\
0 & 0 & 0 & b_{4} & 0 \\
0 & 0 & 0 & 0 & b_{5} \\
\end{bmatrix} \\
\end{array}$$Since the computed Hessian matrix above is everywhere positive definite, it follows that, the objective functional, *Q*(*u* ~1~, *u* ~2~, *u* ~3~, *u* ~4~, *u* ~5~) is strictly convex [@bib0037]. We also have that, $\exists\, b = min\left\{ b_{1},b_{2},b_{3},b_{4},b_{5} \right\} > 0$ given that the integrand of the objective functional,$$\begin{array}{cl}
Q & {= E + A + I + V + \frac{b_{1}}{2}u_{1}^{2} + \frac{b_{2}}{2}u_{2}^{2} + \frac{b_{3}}{2}u_{3}^{2} + \frac{b_{4}}{2}u_{4}^{2} + \frac{b_{5}}{2}u_{5}^{2},} \\
 & {\geq \frac{b_{1}}{2}u_{1}^{2} + \frac{b_{2}}{2}u_{2}^{2} + \frac{b_{3}}{2}u_{3}^{2} + \frac{b_{4}}{2}u_{4}^{2} + \frac{b_{5}}{2}u_{5}^{2},} \\
 & {\geq b\left( u_{1}^{2} + u_{2}^{2} + u_{3}^{2} + u_{4}^{2} + u_{5}^{2} \right),} \\
\end{array}$$holds under the condition $E + A + I + V \geq 0.$ Applying Pontryagin's maximum principle where we have the state variables as $S = S^{{}^{\bigstar}},$ $E = E^{{}^{\bigstar}},$ $A = A^{{}^{\bigstar}},$ $I = I^{{}^{\bigstar}},$ $R = R^{{}^{\bigstar}}$ and $V = V^{{}^{\bigstar}}$ gives the Hamiltonian function;$$\begin{array}{ccl}
H & = & {E^{\bigstar} + A^{\bigstar} + I^{\bigstar} + V^{\bigstar} + \frac{b_{1}}{2}u_{1}^{2} + \frac{b_{2}}{2}u_{2}^{2} + \frac{b_{3}}{2}u_{3}^{2} + \frac{b_{4}}{2}u_{4}^{2} + \frac{b_{5}}{2}u_{5}^{2}} \\
 & & {+ \lambda_{1}\left\lbrack \left( 1 - u_{1} \right)\Lambda - \omega S^{\bigstar} - \left( 1 - u_{2} \right)\beta\left( I^{\bigstar}S^{\bigstar} + \eta A^{\bigstar}S^{\bigstar} \right) \right.} \\
 & & {\quad\left. - \left( 1 - u_{2} - u_{3} \right)\beta_{1}V^{\bigstar}S^{\bigstar} \right\rbrack} \\
 & & {+ \lambda_{2}\left\lbrack \left( 1 - u_{2} \right)\beta\left( I^{\bigstar}S^{\bigstar} + \eta A^{\bigstar}S^{\bigstar} \right) + \left( 1 - u_{2} - u_{3} \right)\beta_{1}V^{\bigstar}S^{\bigstar} \right.} \\
 & & {\quad\left. - k_{1}\gamma E^{\bigstar} - k_{2}\left( 1 - \lambda \right)E^{\bigstar} - \omega E^{\bigstar} \right\rbrack} \\
 & & {+ \lambda_{3}\left\lbrack k_{2}\left( 1 - \gamma \right)E^{\bigstar} - \omega A^{\bigstar} - v_{1}\phi A^{\bigstar} - v_{2}\left( 1 - \phi \right)A^{\bigstar} \right\rbrack} \\
 & & {+ \lambda_{4}\left\lbrack k_{1}\gamma E^{\bigstar} + v_{1}\phi A^{\bigstar} - \epsilon I^{\bigstar} - \left( \omega + \alpha \right)I^{\bigstar} \right\rbrack} \\
 & & {+ \lambda_{5}\left\lbrack v_{2}\left( 1 - \phi \right)A^{\bigstar} + \epsilon I^{\bigstar} - \omega R^{\bigstar} \right\rbrack + \lambda_{6}\left\lbrack \left( 1 - u_{4} \right)m_{1}A^{\bigstar} \right.} \\
 & & {\quad\left. + \left( 1 - u_{4} \right)m_{2}I^{\bigstar} - \left( u_{5} + \tau_{1} \right)V^{\bigstar} \right\rbrack.} \\
\end{array}$$We now take into accounts the existence of the adjoint function *λ~i~*, $i = 1,2,3\ldots 6,$ such that they satisfy the equations;$$\begin{array}{ccl}
\frac{d\lambda_{1}}{\mathit{dt}} & = & {- \frac{\partial H}{\partial S^{\bigstar}},} \\
 & = & {\lambda_{1}\left\lbrack \omega + \left( 1 - u_{2} \right)\beta\left( I^{\bigstar} + \eta A^{\bigstar} \right) + \left( 1 - u_{2} - u_{3} \right)\beta_{1}V^{\bigstar} \right\rbrack} \\
 & & {- \lambda_{2}\left\lbrack \omega + \left( 1 - u_{2} \right)\beta\left( I^{\bigstar} + \eta A^{\bigstar} \right) + \left( 1 - u_{2} - u_{3} \right)\beta_{1}V^{\bigstar} \right\rbrack;} \\
\frac{d\lambda_{2}}{\mathit{dt}} & = & {- \frac{\partial H}{\partial E^{\bigstar}},} \\
 & = & {- 1 + \lambda_{2}\left\lbrack k_{1}\gamma + k_{2}\left( 1 - \gamma \right) + \omega \right\rbrack - \lambda_{3}k_{2}\left( 1 - \gamma \right) - \lambda_{4}k_{1}\gamma;} \\
\frac{d\lambda_{3}}{\mathit{dt}} & = & {- \frac{\partial H}{\partial A^{\bigstar}},} \\
 & = & {- 1 + \lambda_{1}\left( 1 - u_{2} \right)\beta\eta S^{\bigstar} - \lambda_{2}\left( 1 - u_{2} \right)\beta\eta S^{\bigstar}} \\
 & & {+ \lambda_{3}\left\lbrack \omega + v_{1}\phi + v_{2}\left( 1 - \phi \right) \right\rbrack - \lambda_{4}v_{1}\phi} \\
 & & {- \lambda_{5}v_{2}\left( 1 - \phi \right) - \lambda_{6}\left( 1 - u_{4} \right)m_{1};} \\
\frac{d\lambda_{4}}{\mathit{dt}} & = & {- \frac{\partial H}{\partial I^{\bigstar}},} \\
 & = & {- 1 + \lambda_{1}\left( 1 - u_{2} \right)\beta S^{\bigstar} - \lambda_{2}\left( 1 - u_{2} \right)\beta S^{\bigstar}} \\
 & & {+ \lambda_{4}\left\lbrack \epsilon + \omega + \alpha \right\rbrack - \lambda_{5}\epsilon - \lambda_{6}\left( 1 - u_{4} \right)m_{2};} \\
\frac{d\lambda_{5}}{\mathit{dt}} & = & {- \frac{\partial H}{\partial R^{\bigstar}},} \\
 & = & {\lambda_{5}\omega;} \\
\frac{d\lambda_{6}}{\mathit{dt}} & = & {- \frac{\partial H}{\partial V^{\bigstar}},} \\
 & = & {- 1 + \lambda_{1}\left( 1 - u_{2} - u_{3} \right)\beta_{1}S^{\bigstar} - \lambda_{2}\left( 1 - u_{2} - u_{3} \right)\beta_{1}S^{\bigstar}} \\
 & & {+ \lambda_{6}\left( u_{5} + \tau_{1} \right);} \\
\end{array}$$with the transversality condition $\lambda_{i}\left( t_{f} \right) = 0$ given that ∀*u~i~* where $i = 1,2,\ldots,5,$ we have$$\frac{\partial H}{\partial u_{i}} = 0.$$The optimal control strategies with respect to the befitting variation argument is given as;$$\begin{array}{rcl}
u_{1}^{\bigstar} & = & {\text{min}\left\{ \text{max}\left( 0,\frac{\lambda_{1}\Lambda}{b_{1}} \right),u_{1\text{max}} \right\};} \\
u_{2}^{\bigstar} & = & {\text{min}\left\{ \text{max}\left( 0,\frac{\left( - \lambda_{1} + \lambda_{2} \right)\left\lbrack \beta\left( I^{\bigstar}S^{\bigstar} + nA^{\bigstar}S^{\bigstar} \right) + \beta_{1}V^{\bigstar}S^{\bigstar} \right\rbrack}{b_{2}} \right),u_{2\text{max}} \right\};} \\
u_{3}^{\bigstar} & = & {\text{min}\left\{ \text{max}\left( 0,\frac{\left( - \lambda_{1} + \lambda_{2} \right)\beta_{1}V^{\bigstar}S^{\bigstar}}{b_{3}} \right),u_{3\text{max}} \right\};} \\
u_{4}^{\bigstar} & = & {\text{min}\left\{ \text{max}\left( 0,\frac{\lambda_{6}\left\lbrack m_{1}A^{\bigstar} + m_{2}I^{\bigstar} \right\rbrack}{b_{4}} \right),u_{4\text{max}} \right\};} \\
u_{5}^{\bigstar} & = & {\text{min}\left\{ \text{max}\left( 0,\frac{\lambda_{6}V^{\bigstar}}{b_{5}} \right),u_{5\text{max}} \right\}.} \\
\end{array}$$We progress with the numerical simulations on the optimal control by using the estimated parameters in [Table 2](#tbl0002){ref-type="table"}.

4.1. Numerical results of the optimal control analysis {#sec0013}
------------------------------------------------------

Using the forward-backward sweep method as introduced by Lenhart and Workman [@bib0049]; and extensively explored by [@bib0028], [@bib0050], [@bib0051], [@bib0052] and the references therein. We considered the following equal weight factors, initial data for the state variables along with the parameter values, thus $b_{1} = 10,b_{2} = 10,b_{3} = 10,b_{4} = 10,b_{5} = 10$; $S\left( 0 \right) = 30416000,E\left( 0 \right) = 5,A\left( 0 \right) = 5,I\left( 0 \right) = 2,R\left( 0 \right) = 0,V\left( 0 \right) = 0$; $\Lambda = 1319.294,\omega = 0.10142578,\beta = 0.0001,\eta = 0.62811041,\beta_{1} = 0.0001,k_{1} = 0.07142238,k_{2} = 0.014285824,\gamma,\mspace{6mu} = 0.0374,\mspace{6mu} v_{1} = 0.20005051,v_{2} = 0.79999398,\phi = 0.10500005,\epsilon = 0.0805840,\alpha = 0.00440000,\mspace{6mu} m_{1} = 0.71780400,m_{2} = 0.52152716,\tau_{1} = 0.2900000$ for the numerical simulations of the optimal control problem. From [Figs. 9](#fig0009){ref-type="fig"} a--[9](#fig0009){ref-type="fig"} d, the solution trajectories which considers the individual effects of each of the control variables, $u_{i},i = 1,2,\ldots,5$ on the *E, A, I* and *V* population were figured out respectively. The red lines depict the uncontrolled population while the blue lines show the controlled population. These control measures were all highly significant in reducing the asymptomatic and the virus in the populations as compared to the exposed and severely infected populations. It can be inferred here that, adapting to these measures effectively minimize the rate of virus into the environment decreasing the rate of transmission through the environment which was very sensitive in the previous analysis, see [Fig. 4](#fig0004){ref-type="fig"}. More to this, [Fig. 10](#fig0010){ref-type="fig"} demonstrates the solution trajectories by implementing all the control variables on the *E, A, I* and *V* populations with increase in time. Similarly, the red line represents the uncontrolled case while the blue line illustrates the collective controlled state.Fig. 9Solution trajectories showing the effects of the combined efforts of optimal control strategies $u_{i}\,\left( i = 1,2,\ldots,5 \right)$ on the *E, A, I* and *V* populations for 90 days.Fig. 9Fig. 10Solution trajectories showing the effects of the combined efforts of optimal control strategies $u_{i}\,\left( i = 1,2,\ldots,5 \right)$ on the *E, A, I* and *V* populations for 300 days.Fig. 10

[Figs. 9](#fig0009){ref-type="fig"}e, f, [10](#fig0010){ref-type="fig"}e and f illustrate the optimal profile effects of respective controls *u* ~1~, *u* ~2~, *u* ~3~, *u* ~4~ and *u* ~5~ on COVID-19 transmission dynamics in the population and the environment. [Fig. 11](#fig0011){ref-type="fig"} represents the effect of control *u* ~1~ on COVID-19 transmission dynamics in the population and the environment. Comparisons of the dynamics of the subpopulations of exposed, asymptomatic, and symptomatic individuals and the number of virus with control *u* ~2~ and without any control implementation is demonstrated by [Fig. 12](#fig0012){ref-type="fig"} . [Fig. 13](#fig0013){ref-type="fig"}, [Fig. 14](#fig0014){ref-type="fig"}, [Fig. 15](#fig0015){ref-type="fig"} shows the respective dynamics when control *u* ~3~, *u* ~4~ and *u* ~5~ is used separately. It is revealed that the application of the control delayed the COVID-19 virus to peak, and significantly reduces the virus prevalence in the population and the size of the virus present in the community. It is observed that the numbers of exposed, asymptomatic, severely infected individuals, as well as the number of virus with control diminish more rapidly than when there is no control. It is seen that the separate use of any of the three controls causes a sharp decrease in the number of human infections as well as the number of virus presents in the community. To achieve an optimal control of COVID-19 at a minimized cost, then the following ideas deduced from numerical simulation's results in [Figs. 9](#fig0009){ref-type="fig"}e, f, [10](#fig0010){ref-type="fig"} e and f can be adhered to: Considering the trajectory of the control measure *u* ~1~, it can be seen that, *u* ~1~ should be maintained at 0.5005 for the whole period until the 90th day then maintained at 0.499 after day 90 as shown in [Fig. 10](#fig0010){ref-type="fig"}e. For the control measure *u* ~2~, efforts must be implemented around 0.5005. Similarly, efforts on *u* ~3~ also behave like *u* ~2~. The major differences are that; the maximum effort which can be applied on *u* ~3~ is around 0.50046 as compared to 0.5005 in *u* ~2~ as shown in [Fig. 10](#fig0010){ref-type="fig"}e and f. Given that the disease continues to persist within the 90 days, then the regulation on *u* ~4~ is that, efforts must start from 0.4996 after day 90 as shown in [Fig. 10](#fig0010){ref-type="fig"}f. Lastly, efforts on *u* ~5~ must start around 0.4998 and gradually increased to around 0.5008. This effort has to be also maintained until the 90th day and maintained at 0.4998 after day 90 as shown in [Fig. 10](#fig0010){ref-type="fig"}f. In a nut shell, the results of our optimal control analysis guarantee that, ensuring the effective utilization of the above-mentioned optimal control strategies will significantly contribute to the reduction in the spread within the susceptible population. This will far help to minimize the numerous effects which might have been experienced in the days ahead as far as the pandemic is concerned.Fig. 11The optimal effect of applying only control *u*~1~.Fig. 11Fig. 12The optimal effect of applying only control *u*~2~.Fig. 12Fig. 13The optimal effect of applying only control *u*~3~.Fig. 13Fig. 14The optimal effect of applying only control *u*~4~.Fig. 14Fig. 15The optimal effect of applying only control *u*~5~.Fig. 15

4.2. Cost-effectiveness analysis {#sec0014}
--------------------------------

Here, cost-effectiveness analysis is carried out based on the numerical implementation of the optimality system conducted in [Section 4](#sec0012){ref-type="sec"}. The cost benefits associated with the implementation of the control strategies can be compared through cost-effectiveness analysis. Thus, following the approach used in several previous studies [@bib0053], [@bib0054], [@bib0055], [@bib0056], the incremental cost-effectiveness ratio (ICER) is calculated to determine the most cost-effective strategy of all the different control intervention strategies considered in this work. Most often, ICER is employed to measure up the changes between the costs and the health benefits of any two different control intervention strategies *i* and *j* competing for the same limited resources. ICER is defined mathematically as$$\text{ICER} = \frac{\text{Difference}\text{in}\text{costs}\text{of}\text{control}\text{strategies} i\text{and} j}{\text{Difference}\text{in}\text{infections}\text{averted}\text{by}\text{control}\text{strategies} i\text{and} j}.$$

The numerator of ICER in [Eq. (21)](#eq0021){ref-type="disp-formula"} consists of the differences in intervention costs, averted disease costs and costs of prevented cases among others. While the ICER denominator measures the difference in health outcome, which includes the total population of infection averted or total number of cases of susceptibility prevented as the case may be.

Owing to the simulation results of the optimality system, the six control strategies, namely, Strategy 1 (u~1~ only), Strategy 2 (u~2~ only), Strategy 3 (u~3~ only), Strategy 4 (u~4~ only), Strategy 5 (u~5~ only) and Strategy 6 (which combines the use of controls ui, i = 1, 2, ... , 5) are ranked in increasing order of total number of infections averted as presented in [Table 4](#tbl0004){ref-type="table"} .Table 4Strategies 1--6 in increasing order of the number of infections averted.Table 4StrategyTotal infections avertedTotal cost (\$)ICERStrategy 64.4136 × 10^9^3.35$7.5902 \times 10^{- 10}$Strategy 47.0065 × 10^9^0.05$- 1.2727 \times 10^{- 9}$Strategy 37.0550 × 10^9^0.80$1.5464 \times 10^{- 8}$Strategy 51.0748 × 10^10^0.45$9.4774 \times 10^{- 11}$Strategy 11.1681 × 10^10^1.25$8.5745 \times 10^{- 10}$Strategy 21.7117 × 10^10^0.80$- 8.2781 \times 10^{- 11}$

Now, ICER is calculated for the intervention Strategies 6 and 4 in order to compare the two competing strategies incrementally as follows:$$\begin{aligned}
{\text{ICER}\left( 6 \right)} & {= \frac{3.35}{4.4136 \times 10^{9}} = 7.5902 \times 10^{- 10},} \\
{\text{ICER}\left( 4 \right)} & {= \frac{0.05 - 3.35}{7.0065 \times 10^{9} - 4.4136 \times 10^{9}} = - 1.2727 \times 10^{- 9},} \\
{\text{ICER}\left( 3 \right)} & {= \frac{0.80 - 0.05}{7.0550 \times 10^{9} - 7.0065 \times 10^{9}} = 1.5464 \times 10^{- 8},} \\
{\text{ICER}\left( 5 \right)} & {= \frac{0.45 - 0.80}{1.0748 \times 10^{10} - 7.0550 \times 10^{9}} = - 9.4774 \times 10^{- 11},} \\
{\text{ICER}\left( 1 \right)} & {= \frac{1.25 - 0.45}{1.1681 \times 10^{10} - 1.0748 \times 10^{10}} = 8.5745 \times 10^{- 10},} \\
{\text{ICER}\left( 2 \right)} & {= \frac{0.80 - 1.25}{1.7117 \times 10^{10} - 1.1681 \times 10^{10}} = - 8.2781 \times 10^{- 11}.} \\
\end{aligned}$$

From [Table 4](#tbl0004){ref-type="table"}, it is observed that the value of ICER(6) is greater than that of ICER(4). This indicates that Strategy 6 is more costly and less effective than Strategy 4. For this reason, Strategy 6 is excluded from the list of alternative control interventions competing for the same limited resources and ICER is recalculated for Strategies 4 and 3 as illustrated by [Table 5](#tbl0005){ref-type="table"} .Table 5Comparison between control intervention Strategies 4 and 3.Table 5StrategyTotal infections avertedTotal cost (\$)ICERStrategy 47.0065 × 10^9^0.05$7.1362 \times 10^{- 12}$Strategy 37.0550 × 10^9^0.80$1.5464 \times 10^{- 8}$Strategy 51.0748 × 10^10^0.45$9.4774 \times 10^{- 11}$Strategy 11.1681 × 10^10^1.25$8.5745 \times 10^{- 10}$Strategy 21.7117 × 10^10^0.80$- 8.2781 \times 10^{- 11}$

It is seen from [Table 5](#tbl0005){ref-type="table"} that the value of ICER(3) is more than the ICER(4) value. The implication of this is that Strategy 3 is strongly dominated, more costly and less effective when compared with Strategy 4. Therefore, Strategy 3 is excluded from the list of alternative interventions and ICER is recalculated for Strategies 4 and 5. The results of the new computation is presented by [Table 6](#tbl0006){ref-type="table"} .Table 6Comparison between control intervention Strategies 4 and 5.Table 6StrategyTotal infections avertedTotal cost (\$)ICERStrategy 47.0065 × 10^9^0.05$7.1362 \times 10^{- 12}$Strategy 51.0748 × 10^10^0.45$1.0691 \times 10^{- 10}$Strategy 11.1681 × 10^10^1.25$8.5745 \times 10^{- 10}$Strategy 21.7117 × 10^10^0.80$- 8.2781 \times 10^{- 11}$

[Table 6](#tbl0006){ref-type="table"} shows that the ICER(4) is lower than ICER(5). Then, it follows that Strategy 5 is more costly and less effective than Strategy 4. Hence, Strategy 5 is excluded from the list of alternative interventions and ICER is recalculated for Strategies 4 and 1 as shown in [Table 7](#tbl0007){ref-type="table"} .Table 7Comparison between control intervention Strategies 4 and 1.Table 7StrategyTotal infections avertedTotal cost (\$)ICERStrategy 47.0065 × 10^9^0.05$7.1362 \times 10^{- 12}$Strategy 11.1681 × 10^10^1.25$2.5671 \times 10^{- 10}$Strategy 21.7117 × 10^10^0.80$- 8.2781 \times 10^{- 11}$

It can be seen in [Table 7](#tbl0007){ref-type="table"} that ICER(1) is greater than ICER(4). This implies that the implementation of Strategy 1 is more costly and less effective than the implementation of Strategy 4. Hence, Strategy 1 is discarded from the list of alternative control intervention strategies competing for the same limited resources. Now, the ICER is finally recalculated for Strategies 4 and 2 as shown in [Table 8](#tbl0008){ref-type="table"} .Table 8Comparison between control intervention Strategies 4 and 2.Table 8StrategyTotal infections avertedTotal cost (\$)ICERStrategy 47.0065 × 10^9^0.05$7.1362 \times 10^{- 12}$Strategy 21.7117 × 10^10^0.80$7.4180 \times 10^{- 11}$

[Table 8](#tbl0008){ref-type="table"} reveals that ICER(2) is greater than ICER(4). Hence, Strategy 2 is considered to be strongly dominated, more costly and less effective than Strategy 4. Consequently, Strategy 4 (cleaning of surfaces with home based detergents) is the most cost-effective strategy among all the six control intervention strategies under consideration in this work.

5. Concluding remarks {#sec0015}
=====================

With reference to the recent travel restrictions in Ghana and other parts of the world, we formulated COVID-19 dynamics in Ghana as a deterministic model. The purpose of the study was to consider humans as key players in the transmission of this virus. The disease-free equilibrium and endemic equilibrium points were found to be globally asymptotically stable. We found that, the major transmission parameters *β, β* ~1~, *m* ~1~ and *m* ~2~ contributing to the basic reproduction number of $1.99 - 3.37$ were all attributed to humans through personal contact with the susceptible class or activities with the environs. It is further inferred from this study that; applying optimal control strategy on the rate at which the virus is released into the system, *m* ~1~ and *m* ~2~, and also on the relative transmission rate due to human behavior will considerably strike down COVID-19 pandemic.

It was also found that, it might be possible the recovered individuals can be reinfected, see [Fig. 8](#fig0008){ref-type="fig"}b. When this happens, then the number of the infected individuals will also increase. Therefore, we highly recommend that, drug manufacturers should aim at drug samples which will induce permanent immunity in the recovered individuals so as to reduce the susceptible population. Cost-effectiveness analysis was carried out based on the numerical implementation of the optimality system conducted in [Section 4](#sec0012){ref-type="sec"}. This showed that, safety adopted by the asymptomatic and symptomatic individuals such as practicing proper cough etiquette by maintaining a distance, covering coughs and sneezes with disposable tissues or clothing and washing of hands after coughing or sneezing is the most cost-effective strategy, followed by intensifying the usage of nose mask and face shields through education, then the effective testing and quarantine when boarders are opened, fumigating the commercial areas such as markets, cleaning of surfaces with home-based detergents, and lastly, thecombination of all the control interventions analysed in this study. It is highly guaranteed that, this study will help policy makers in the control of the pandemic in Ghana. Further research on this subject and other epidemiological study can be investigated, such as1.The impact of religious activities on the spread and control of the disease;2.Optimal control model which seeks to reduce the disease induced death rate.
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Appendix A. Confirmed cases for Ghana as of 7th May 2020. {#sec0016}
=========================================================

Table A.9Cumulative daily confirmed cases of COVID-19 as of 7th May, 2020 in Ghana.Table A.9Day12th Mar13th Mar14th Mar15th Mar16th Mar17th Mar18th MarCases2222666% Change-00020000Day19th Mar20th Mar21st Mar22nd Mar23rd Mar24th Mar25th MarCases11162124275166% Change83.345.531.314.312.588.929.4Day26th Mar27th28th Mar29th Mar30th Mar31st Mar1st AprilCases68132137137152161195% Change3.094.03.8010.95.921.1Day2nd April3rd April4th April5th April6th April7th April8th AprilCases204205214214287313313% Change4.60.54.4034.19.10Day9th April10th April11th April12th April13th April14th April15th AprilCases378408566566566566641% Change20.77.938.700013.3Day16th April17th April18th April19th April20th April21st April22nd AprilCases6416418341042104210421279% Change0030.117.00022.7Day23rd April24th April25th April26th April27th April28th April29th AprilCases1279127915501550167120742074% Change0021.207.824.10Day30th April1st May2nd May3rd May4th May5th May6th MayCases2074216927192719309130913091% Change04.625.4012.000Day7th MayCases4012% Change12.0
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